The present invention relates to microbiocidal quinoline (thio)carboxamide derivatives, e.g. as active ingredients, which have microbiocidal activity, in particular fungicidal activity. The invention also relates to preparation of these quinoline

(thio)carboxamide derivatives, to intermediates useful in the preparation of these quinoline (thio)carboxamide derivatives, to the preparation of these intermediates, to agrochemical compositions which comprise at least one of the quinoline (thio)carboxamide derivatives, to preparation of these compositions and to the use of the quinoline (thio)carboxamide derivatives or compositions in agriculture or horticulture for controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi.

Certain fungicidal quinoline (thio)carboxamide compounds are described in

WO04039783.

It has now surprisingly been found that certain novel quinoline (thio)carboxamide derivatives have favourable fungicidal properties.

The present invention therefore provides compounds of formula (I)

(I)

wherein

X is O or S;

Ri is hydrogen, halogen, methyl or cyano;

R2 is hydrogen, methyl or halogen;

R3 and R ₄ are each independently selected from hydrogen, halogen and methyl; R5 IS Ci-C ₄ alkyl, C2-C ₄ alkenyl or C3-C6 cycloalkyi, wherein the alkyl, alkenyl and cycloalkyi may be optionally substituted with 1 to 3 substituents independently selected from halogen, cyano, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy and C1-C3 alkylthio;

R6 is hydrogen, cyano or Ci-C ₄ alkyl;

R7 is C ₄ -Cio saturated or partially unsaturated heterocycle or heteroaryl, wherein the heterocycle or heteroaryl contains one, two or three heteroatoms selected from N, O and S, and is connected via a carbon or a nitrogen atom, and may be optionally substituted with one or more substituents independently selected from halogen, cyano, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 alkylthio; C1-C3 haloalkyl, C1-C3 haloalkoxy, C1-C3 haloalkylthio and C3-C5 cycloalkyl; and salts, enantiomers and/or N-oxides thereof. In a second aspect the present invention provides an agrochemical composition comprising a compound of formula (I).

Compounds of formula (I) may be used to control phytopathogenic microorganisms.

Thus, in order to control a phytopathogen a compound of formula (I), or a composition comprising a compound of formula (I), according to the invention may be applied directly to the phytopathogen, or to the locus of a phytopathogen, in particular to a plant susceptible to attack by phytopathogens.

Thus, in a third aspect the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to control a phytopathogen.

In a further aspect the present invention provides a method of controlling

phytopathogens, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogen, or to the locus of said phytopathogen, in particular to a plant susceptible to attack by a

phytopathogen.

Compounds of formula (I) are particularly effective in the control of phytopathogenic fungi.

Thus, in a yet further aspect the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to control phytopathogenic fungi.

In a further aspect the present invention provides a method of controlling

phytopathogenic fungi, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein to said phytopathogenic fungi, or to the locus of said phytopathogenic fungi, in particular to a plant susceptible to attack by phytopathogenic fungi.

Where substituents are indicated as being optionally substituted, this means that they may or may not carry one or more identical or different substituents, e.g. one to four substituents. Normally not more than three such optional substituents are present at the same time. Preferably not more than two such optional substituents are present at the same time (i.e. the group may be optionally substituted by one or two of the substituents indicated as "optional"). Where the "optional substituent" group is a larger group, such as cycloalkyl or phenyl, it is most preferred that only one such optional substituent is present. Where a group is indicated as being substituted, e.g. alkyl, this includes those groups that are part of other groups, e.g. the alkyl in alkylthio.

The term "halogen" refers to fluorine, chlorine, bromine or iodine, preferably fluorine, chlorine or bromine.

Alkyl substituents (either alone or as part of a larger group, such as alkoxy-, alkylthio-) may be straight-chained or branched. Alkyl on its own or as part of another substituent is, depending upon the number of carbon atoms mentioned, for example, methyl, ethyl, n- propyl, n-butyl, n-pentyl, n-hexyl and the isomers thereof, for example, iso-propyl, iso-butyl, sec-butyl, ie f-butyl or iso-amyl.

Alkenyl substituents (either alone or as part of a larger group, eg. alkenyloxy) can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E)- or (Z)-configu ration. Examples are vinyl and allyl. The alkenyl groups are preferably C2-C6, more preferably C2-C ₄ and most preferably C2-C3 alkenyl groups.

Alkynyl substituents (either alone or as part of a larger group, eg. alkynyloxy) can be in the form of straight or branched chains. Examples are ethynyl and propargyl. The alkynyl groups are preferably C2-C6, more preferably C2-C ₄ and most preferably C2-C3 alkynyl groups.

Cycloalkyl substituents may be saturated or partially unsaturated, preferably fully saturated, and are, for example, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

Haloalkyl groups (either alone or as part of a larger group, eg. haloalkyloxy) may contain one or more identical or different halogen atoms and, for example, may stand for CH2CI, CHC , CCIs, CH2F, CHF ₂ , CF ₃ , CF3CH2, CH3CF2, CF3CF2 or CCI3CCI2.

Haloalkenyl groups (either alone or as part of a larger group, eg. haloalkenyloxy) are alkenyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, for example, 2,2-difluorovinyl or 1 ,2-dichloro-2-fluoro-vinyl.

Haloalkynyl groups (either alone or as part of a larger group, eg. haloalkynyloxy) are alkynyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, for example, 1 -chloro-prop-2-ynyl.

Alkoxy means a radical -OR, where R is alkyl, e.g. as defined above. Alkoxy groups include, but are not limited to, methoxy, ethoxy, 1 -methylethoxy, propoxy, butoxy, 1 - methylpropoxy and 2-methylpropoxy.

Cyano means a -CN group.

Amino means an -IMH2 group.

Hydroxyl or hydroxy stands for a -OH group.

Aryl groups (either alone or as part of a larger group, such as e.g. aryloxy, aryl-alkyl) are aromatic ring systems which can be in mono-, bi- or tricyclic form. Examples of such rings include phenyl, naphthyl, anthracenyl, indenyl or phenanthrenyl. Preferred aryl groups are phenyl and naphthyl, phenyl being most preferred. Where an aryl moiety is said to be substituted, the aryl moiety is preferably substituted by one to four substituents, most preferably by one to three substituents.

Heteroaryl groups (either alone or as part of a larger group, such as e.g.

heteroaryloxy, heteroaryl-alkyl) are aromatic ring systems containing at least one heteroatom and consisting either of a single ring or of two or more fused rings. Preferably, single rings will contain up to three heteroatoms and bicyclic systems up to four heteroatoms which will preferably be chosen from nitrogen, oxygen and sulfur. Examples of monocyclic groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl (e.g.

[1 ,2,4] triazolyl), furanyl, thiophenyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl and thiadiazolyl. Examples of bicyclic groups include purinyl, quinolinyl, cinnolinyl, quinoxalinyl, indolyl, indazolyl, benzimidazolyl, benzothiophenyl and benzothiazolyl.

Monocyclic heteroaryl groups are preferred, pyridyl being most preferred. Where a heteroaryl moiety is said to be substituted, the heteroaryl moiety is preferably substituted by one to four substituents, most preferably by one to three substituents.

Heterocyclyl groups, heterocycles or heterocyclic rings (either alone or as part of a larger group, such as heterocyclyl-alkyl) are non-aromatic ring structures containing up to 10 atoms including one or more (preferably one, two or three) heteroatoms selected from O, S and N. Examples of monocyclic groups include, oxetanyl, 4,5-dihydro-isoxazolyl, thietanyl, pyrrolidinyl, tetrahydrofuranyl, [1 ,3]dioxolanyl, piperidinyl, piperazinyl, [1 ,4]dioxanyl, imidazolidinyl, [1 ,3,5]oxadiazinanyl, hexahydro-pyrimidinyl, [1 ,3,5]triazinanyl and morpholinyl or their oxidised versions such as 1 -oxo-thietanyl and 1 ,1 -dioxo-thietanyl. Examples of bicyclic groups include 2,3-dihydro-benzofuranyl, benzo[1 ,4]dioxolanyl, benzo[1 ,3]dioxolanyl, chromenyl, and 2,3-dihydro-benzo[1 ,4]dioxinyl. Where a heterocyclyl moiety is said to be substituted, the heterocyclyl moiety is preferably substituted by one to four substituents, most preferably by one to three substituents.

The presence of one or more possible asymmetric carbon atoms in a compound of formula (I) means that the compounds may occur in optically isomeric forms, i.e.

enantiomeric or diastereomeric forms. Also atropisomers may occur as a result of restricted rotation about a single bond. Formula (I) is intended to include all those possible isomeric forms and mixtures thereof. The present invention includes all those possible isomeric forms and mixtures thereof for a compound of formula (I). Likewise, formula (I) is intended to include all possible tautomers. The present invention includes all possible tautomeric forms for a compound of formula (I).

In each case, the compounds of formula (I) according to the invention are in free form, in oxidized form as a N-oxide or in salt form, e.g. an agronomically usable salt form. N-oxides are oxidized forms of tertiary amines or oxidized forms of nitrogen containing heteroaromatic compounds. They are described for instance in the book

"Heterocyclic N-oxides" by A. Albini and S. Pietra, CRC Press, Boca Raton 1991 . Preferred values of X, Ri, R2, R3, R ₄ , R5, R6 and R7 are, in any combination thereof, as set out below:

Preferably X is O.

Preferably Ri is hydrogen, fluoro, chloro, methyl or cyano.

More preferably Ri is hydrogen, fluoro, chloro or methyl.

Most preferably Ri is fluoro, chloro or methyl.

Preferably R2 is hydrogen, methyl, chloro or fluoro.

More preferably R2 is hydrogen, chloro or fluoro.

Most preferably R2 is hydrogen or fluoro.

Preferably R3 and R ₄ are each independently selected from hydrogen and methyl. More preferably R3 IS methyl and R ₄ is hydrogen; or R3 IS hydrogen and R ₄ is methyl; or R3 IS hydrogen and R ₄ is hydrogen.

Most preferably Rs and R ₄ are both hydrogen.

Preferably Rs is Ci-C ₄ alkyl, C2-C ₄ alkenyl or C3-C6 cycloalkyi, wherein the alkyl, alkenyl and cycloalkyi may be optionally substituted with 1 to 3 substituents independently selected from fluoro, chloro and C1-C3 alkyl.

More preferably Rs is Ci-C ₄ alkyl, C2-C3 alkenyl, cyclopropyl or cyclobutyl, wherein the alkyl, alkenyl, cyclopropyl and cyclobutyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group.

Most preferably Rs is trifluoromethyl, ethyl, isopropyl, tert-butyl, C2-alkenyl or cyclopropyl, wherein the ethyl, isopropyl, alkenyl and cyclopropyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group.

Preferably R6 is hydrogen or C1-C3 alkyl.

More preferably R6 is hydrogen, methyl or ethyl.

Most preferably R6 is methyl.

Preferably R7 is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=0, C=CH2 or C=CF2), pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl, tetrahydropyranyl, tetrahydrofuranyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H- pyridazinyl, tetrahydropyranyl, tetrahydrofuranyl and pyridinyl may be optionally substituted with one or more substituents independently selected from fluoro, chloro, cyano, C1-C3 alkyl, C1-C3 haloalkyl and C3-C4 cycloalkyl.

More preferably R7 is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=CF2), oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro- 3H-pyridazinyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4- oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl, trifluoromethyl and cyclopropyl.

Even more preferably R7 is thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=CF2) or pyridinyl, wherein the thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl, and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl or trifluoromethyl.

Most preferably R7 is thienyl, thiazolyl, pyridinyl or piperidyl (wherein one of the ring- member methylene groups may optionally represent C=CF2), wherein the thienyl, thiazolyl, pyridinyl and piperidyl may be optionally substituted with one or two substituents

independently selected from fluoro, chloro, methyl or trifluoromethyl.

Embodiments according to the invention are provided as set out below.

Embodiment 1 provides compounds of formula (I), or a salt, enantiomer or N-oxide thereof, as defined above.

Embodiment 2 provides compounds according to embodiment 1 , or a salt, enantiomer or N-oxide thereof, wherein Ri is hydrogen, fluoro, chloro, methyl or cyano.

Embodiment 3 provides compounds according to embodiment 1 or 2, or a salt, enantiomer or N-oxide thereof, wherein R2 is hydrogen, methyl, chloro or fluoro.

Embodiment 4 provides compounds according to any one of embodiments 1 , 2 or 3, or a salt, enantiomer or N-oxide thereof, wherein R3 and R ₄ are each independently selected from hydrogen and methyl.

Embodiment 5 provides compounds according to any one of embodiments 1 , 2, 3 or 4, or a salt, enantiomer or N-oxide thereof, wherein R ₅ is C1-C4 alkyl, C2-C4 alkenyl or C3-C6 cycloalkyl, wherein the alkyl, alkenyl and cycloalkyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro, chloro and C1-C3 alkyl.

Embodiment 6 provides compounds according to any one of embodiments 1 , 2, 3, 4, or 5, or a salt, enantiomer or N-oxide thereof, wherein R6 is hydrogen or C1-C3 alkyl. Embodiment 7 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, or 6, or a salt, enantiomer or N-oxide thereof, wherein R ₇ is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=0, C=CH2 or C=CF2), pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl and pyridinyl may be optionally substituted with one or more substituents independently selected from fluoro, chloro, cyano, C1-C3 alkyl, C1-C3 haloalkyl and C3-C4 cycloalkyl.

Embodiment 8 provides compounds according to any one of embodiments 1 , 2, 3, 4,

5, 6, or 7, or a salt, enantiomer or N-oxide thereof, wherein Ri is hydrogen, fluoro, chloro or methyl.

Embodiment 9 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, or 8, or a salt, enantiomer or N-oxide thereof, wherein R2 is hydrogen, chloro or fluoro.

Embodiment 10 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, or 9, or a salt, enantiomer or N-oxide thereof, wherein R3 is methyl and R ₄ is hydrogen; or R3 IS hydrogen and R ₄ is methyl; or R3 IS hydrogen and R ₄ is hydrogen.

Embodiment 1 1 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9 or 10, or a salt, enantiomer or N-oxide thereof, wherein R ₅ is C1-C4 alkyl, C2-C3 alkenyl, cyclopropyl or cyclobutyl, wherein the alkyl, alkenyl, cyclopropyl and cyclobutyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group.

Embodiment 12 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10 or 1 1 , or a salt, enantiomer or N-oxide thereof, wherein R6 is hydrogen, methyl or ethyl.

Embodiment 13 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 or 12, or a salt, enantiomer or N-oxide thereof, wherein R ₇ is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=CF2), oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl, trifluoromethyl and cyclopropyl. Embodiment 14 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12 or 13, or a salt, enantiomer or N-oxide thereof, wherein Ri is fluoro, chloro or methyl.

Embodiment 15 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13 or 14, or a salt, enantiomer or N-oxide thereof, wherein R2 is hydrogen or fluoro.

Embodiment 16 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14 or 15, or a salt, enantiomer or N-oxide thereof, wherein F¾ and R ₄ are both hydrogen.

Embodiment 17 provides compounds according to any one of embodiments 1 , 2, 3, 4,

5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15 or 16, or a salt, enantiomer or N-oxide thereof, wherein R ₅ is trifluoromethyl, ethyl, isopropyl, tert-butyl, C2-alkenyl or cyclopropyl, wherein the ethyl, isopropyl, alkenyl and cyclopropyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group.

Embodiment 18 provides compounds according to any one of embodiments 1 , 2, 3, 4,

5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16 or 17, or a salt, enantiomer or N-oxide thereof, wherein R6 is methyl.

Embodiment 19 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17 or 18, or a salt, enantiomer or N-oxide thereof, wherein R ₇ is thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring- member methylene groups may optionally represent C=CF2) or pyridinyl, wherein the thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl, and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl or trifluoromethyl.

Embodiment 20 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18 or 19, or a salt, enantiomer or N-oxide thereof, wherein R ₇ is thienyl, thiazolyl or piperidyl (wherein one of the ring-member methylene groups may optionally represent C=CF2), wherein the thienyl, thiazolyl and piperidyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl or trifluoromethyl.

Embodiment 21 provides compounds according to any one of embodiments 1 , 2, 3, 4,

5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, or a salt, enantiomer or N-oxide thereof, wherein X is O.

Embodiment 22 provides compounds according to any one of embodiments 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 or 20, or a salt, enantiomer or N-oxide thereof, wherein X is S.

One group of compounds according to the invention are those of formula (Γ):

(Ι')

wherein Ri , R2, R3, R ₄ , R5, R6 and R7 are as defined for compounds of formula (I), or a salt, enantiomer or N-oxide thereof. Preferred definitions of Ri , R2, R3, R ₄ , R5, R6 and R7 are as defined for compounds of formula (I).

One group of compounds according to the invention are those of formula (!"):

(I")

wherein Ri , R2, R3, R ₄ , R5, R6 and R7 are as defined for compounds of formula (I), or a salt, enantiomer or N-oxide thereof. Preferred definitions of Ri , R2, R3, R ₄ , R5, R6 and R7 are as defined for compounds of formula (I).

A preferred group of compounds according to the invention are those of formula (1-1 ) which are compounds of formula (I) wherein X is O or S; Ri is hydrogen, fluoro, chloro, methyl or cyano; R2 is hydrogen, methyl, chloro or fluoro; R3 and R ₄ are each independently selected from hydrogen and methyl; R ₅ is Ci-C ₄ alkyl, C2-C ₄ alkenyl or C3-C6 cycloalkyl, wherein the alkyl, alkenyl and cycloalkyl may be optionally substituted with 1 to 3

substituents independently selected from fluoro, chloro and C1-C3 alkyl; R6 is hydrogen or Ci- C3 alkyl; R ₇ is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=0, C=CH2 or C=CF2), pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5- dihydro-3H-pyridazinyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4- oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, pyridazinyl, oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl and pyridinyl may be optionally substituted with one or more substituents independently selected from fluoro, chloro, cyano, C1-C3 alkyl, C1-C3 haloalkyl and C3-C4 cycloalkyl; or a salt, enantiomer or N-oxide thereof.

One group of compounds according to this embodiment are compounds of formula (I- 1 a) which are compounds of formula (1-1 ) wherein X is O.

Another group of compounds according to this embodiment are compounds of formula (1-1 b) which are compounds of formula (1-1 ) wherein X is S.

A further preferred group of compounds according to the invention are those of formula (I-2) which are compounds of formula (I) wherein X is O or S; Ri is hydrogen, fluoro, chloro or methyl; R2 is hydrogen, chloro or fluoro; R3 IS methyl and R ₄ is hydrogen; or R3 IS hydrogen and R ₄ is methyl; or R3 IS hydrogen and R ₄ is hydrogen; R ₅ is C1-C4 alkyl, C2-C3 alkenyl, cyclopropyl or cyclobutyl, wherein the alkyl, alkenyl, cyclopropyl and cyclobutyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group; R6 is hydrogen, methyl or ethyl; R ₇ is thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring- member methylene groups may optionally represent C=CF2), oxazinanyl, thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl or pyridinyl, wherein the thienyl, azetidinyl, pyrazolyl, oxazolyl, 1 ,2,4-oxadiazolyl, thiazolyl, pyrrolidinyl, piperidyl, oxazinanyl,

thiomorpholinyl, morpholinyl, indazolyl, 4,5-dihydro-3H-pyridazinyl and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl, trifluoromethyl and cyclopropyl; or a salt, enantiomer or N-oxide thereof.

One group of compounds according to this embodiment are compounds of formula (I- 2a) which are compounds of formula (I-2) wherein X is O.

Another group of compounds according to this embodiment are compounds of formula (l-2b) which are compounds of formula (I-2) wherein X is S.

A further preferred group of compounds according to the invention are those of formula (I-3) which are compounds of formula (I) wherein X is O or S; Ri is fluoro, chloro or methyl; R2 is hydrogen or fluoro; Rs and R ₄ are both hydrogen; R ₅ is trifluoromethyl, ethyl, isopropyl, tert-butyl, C2-alkenyl or cyclopropyl, wherein the ethyl, isopropyl, alkenyl and cyclopropyl may be optionally substituted with 1 to 3 substituents independently selected from fluoro and chloro or one methyl group; R6 is methyl; R ₇ is thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl (wherein one of the ring-member methylene groups may optionally represent C=CF2) or pyridinyl, wherein the thienyl, azetidinyl, thiazolyl, pyrrolidinyl, piperidyl, and pyridinyl may be optionally substituted with one or two substituents independently selected from fluoro, chloro, methyl or trifluoromethyl; or a salt, enantiomer or N-oxide thereof. One group of compounds according to this embodiment are compounds of formula (I- 3a) which are compounds of formula (I-3) wherein X is O.

Another group of compounds according to this embodiment are compounds of formula (l-3b) which are compounds of formula (I-3) wherein X is S.

Compounds according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against diseases that are caused by fungi or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased

biodegradability).

Specific examples of compounds of formula (I) are illustrated in the Tables A1 to A8 below: Table A1 provides 324 compounds of formula (l-a)

wherein Ri, R2, R ₃ and R ₄ are all H

and wherein the values of R5, R6 and R7 are as defined in Table Z below:

Table Z

Entry R ₅ Re R ₇

1 CH ₂ CH(CH ₃ ) ₂ H 2-thienyl

2 CH2CF3 H 2-thienyl

3 CH ₂ cyclopropyl H 2-thienyl

4 CH ₂ C(CH ₃ ) ₃ H 2-thienyl

5 CH ₂ CH(CH ₃ ) ₂ H 3-thienyl

6 CH ₂ CF ₃ H 3-thienyl

7 CH ₂ cyclopropyl H 3-thienyl

8 CH ₂ C(CH ₃ ) ₃ H 3-thienyl

9 CH ₂ CH(CH ₃ ) ₂ H 5-F-2-thienyl

10 CH ₂ CF ₃ H 5-F-2-thienyl

1 1 CH ₂ cyclopropyl H 5-F-2-thienyl

12 CH ₂ C(CH ₃ ) ₃ H 5-F-2-thienyl

13 CH ₂ CH(CH ₃ ) ₂ H 5-F-3-thienyl Entry R ₅ Re R ₇

14 CH2CF3 H 5-F-3-thienyl

15 CH ₂ cyclopropyl H 5-F-3-thienyl

16 CH ₂ C(CH ₃ ) ₃ H 5-F-3-thienyl

17 CH ₂ CH(CH ₃ ) ₂ H 5-CI-2-thienyl

18 CH2CF3 H 5-CI-2-thienyl

19 CH ₂ cyclopropyl H 5-CI-2-thienyl

20 CH ₂ C(CH ₃ ) ₃ H 5-CI-2-thienyl

21 CH ₂ CH(CH ₃ ) ₂ H 5-CI-3-thienyl

22 CH ₂ CF ₃ H 5-CI-3-thienyl

23 CH ₂ cyclopropyl H 5-CI-3-thienyl

24 CH ₂ C(CH ₃ ) ₃ H 5-CI-3-thienyl

25 CH ₂ CH(CH ₃ ) ₂ H 3,3-d ifluoro-1 -azetidinyl

26 CH ₂ CF ₃ H 3,3-d ifluoro-1 -azetidinyl

27 CH ₂ cyclopropyl H 3, 3-d ifluoro-1 -azetidinyl

28 CH ₂ C(CH ₃ ) ₃ H 3, 3-d ifluoro-1 -azetidinyl

29 CH ₂ CH(CH ₃ ) ₂ H 3, 3-d ifluoro-1 -pyrrolidinyl

30 CH ₂ CF ₃ H 3, 3-d ifluoro-1 -pyrrolidinyl

31 CH ₂ cyclopropyl H 3, 3-d ifluoro-1 -pyrrolidinyl

32 CH ₂ C(CH ₃ ) ₃ H 3, 3-d ifluoro-1 -pyrrolidinyl

33 CH ₂ CH(CH ₃ ) ₂ H 3, 3-d ifluoro-1 -piperidyl

34 CH ₂ CF ₃ H 3, 3-d ifluoro-1 -piperidyl

35 CH ₂ cyclopropyl H 3, 3-d ifluoro-1 -piperidyl

36 CH ₂ C(CH ₃ ) ₃ H 3, 3-d ifluoro-1 -piperidyl

37 CH(CH ₃ ) ₂ CH ₃ 2-thienyl

38 C(CH ₃ )=CH ₂ CH ₃ 2-thienyl

39 C(F)=CH ₂ CH ₃ 2-thienyl

40 C(CH ₃ ) ₃ CH ₃ 2-thienyl

41 CF ₃ CH ₃ 2-thienyl

42 CH=CH ₂ CH ₃ 2-thienyl

43 cyclopropyl CH ₃ 2-thienyl

44 1 -methylcyclopropyl CH ₃ 2-thienyl

45 1 -fluorocyclopropyl CH ₃ 2-thienyl

46 1 -cyanocyclopropyl CH ₃ 2-thienyl

47 CF(CH ₃ ) ₂ CH ₃ 2-thienyl

48 CF ₂ CH ₃ CH ₃ 2-thienyl

49 CH(CH ₃ ) ₂ CH ₃ 3-thienyl Entry R ₅ Re R ₇

50 C(CH ₃ )=CH ₂ CH ₃ 3-thienyl

51 C(F)=CH ₂ CH ₃ 3-thienyl

52 C(CH ₃ ) ₃ CH ₃ 3-thienyl

53 CF ₃ CH ₃ 3-thienyl

54 CH=CH ₂ CH ₃ 3-thienyl

55 cyclopropyl CH ₃ 3-thienyl

56 1 -methylcyclopropyl CH ₃ 3-thienyl

57 1 -fluorocyclopropyl CH ₃ 3-thienyl

58 1 -cyanocyclopropyl CH ₃ 3-thienyl

59 CF(CH ₃ ) ₂ CH ₃ 3-thienyl

60 CF ₂ CH ₃ CH ₃ 3-thienyl

61 CH(CH ₃ ) ₂ CH ₃ 5-F-2-thienyl

62 C(CH ₃ )=CH ₂ CH ₃ 5-F-2-thienyl

63 C(F)=CH ₂ CH ₃ 5-F-2-thienyl

64 C(CH ₃ ) ₃ CH ₃ 5-F-2-thienyl

65 CF ₃ CH ₃ 5-F-2-thienyl

66 CH=CH ₂ CH ₃ 5-F-2-thienyl

67 cyclopropyl CH ₃ 5-F-2-thienyl

68 1 -methylcyclopropyl CH ₃ 5-F-2-thienyl

69 1 -fluorocyclopropyl CH ₃ 5-F-2-thienyl

70 1 -cyanocyclopropyl CH ₃ 5-F-2-thienyl

71 CF(CH ₃ ) ₂ CH ₃ 5-F-2-thienyl

72 CF ₂ CH ₃ CH ₃ 5-F-2-thienyl

73 CH(CH ₃ ) ₂ CH ₃ 5-F-3-thienyl

74 C(CH ₃ )=CH ₂ CH ₃ 5-F-3-thienyl

75 C(F)=CH ₂ CH ₃ 5-F-3-thienyl

76 C(CH ₃ ) ₃ CH ₃ 5-F-3-thienyl

77 CF ₃ CH ₃ 5-F-3-thienyl

78 CH=CH ₂ CH ₃ 5-F-3-thienyl

79 cyclopropyl CH ₃ 5-F-3-thienyl

80 1 -methylcyclopropyl CH ₃ 5-F-3-thienyl

81 1 -fluorocyclopropyl CH ₃ 5-F-3-thienyl

82 1 -cyanocyclopropyl CH ₃ 5-F-3-thienyl

83 CF(CH ₃ ) ₂ CH ₃ 5-F-3-thienyl

84 CF ₂ CH ₃ CH ₃ 5-F-3-thienyl Entry R ₅ Re R ₇

85 CH(CH ₃ ) ₂ CH ₃ 2-F-3-thienyl

86 C(CH ₃ )=CH ₂ CH ₃ 2-F-3-thienyl

87 C(F)=CH ₂ CH ₃ 2-F-3-thienyl

88 C(CH ₃ ) ₃ CH ₃ 2-F-3-thienyl

89 CF ₃ CH ₃ 2-F-3-thienyl

90 CH=CH ₂ CH ₃ 2-F-3-thienyl

91 cyclopropyl CH ₃ 2-F-3-thienyl

92 1 -methylcyclopropyl CH ₃ 2-F-3-thienyl

93 1 -fluorocyclopropyl CH ₃ 2-F-3-thienyl

94 1 -cyanocyclopropyl CH ₃ 2-F-3-thienyl

95 CF(CH ₃ ) ₂ CH ₃ 2-F-3-thienyl

96 CF ₂ CH ₃ CH ₃ 2-F-3-thienyl

97 CH(CH ₃ ) ₂ CH ₃ 2-F-3-thienyl

98 C(CH ₃ )=CH ₂ CH ₃ 2-F-3-thienyl

99 C(F)=CH ₂ CH ₃ 2-F-3-thienyl

100 C(CH ₃ ) ₃ CH ₃ 2-F-3-thienyl

101 CF ₃ CH ₃ 2-F-3-thienyl

102 CH=CH ₂ CH ₃ 2-F-3-thienyl

103 cyclopropyl CH ₃ 2-F-3-thienyl

104 1 -methylcyclopropyl CH ₃ 2-F-3-thienyl

105 1 -fluorocyclopropyl CH ₃ 2-F-3-thienyl

106 1 -cyanocyclopropyl CH ₃ 2-F-3-thienyl

107 CF(CH ₃ ) ₂ CH ₃ 2-F-3-thienyl

108 CF ₂ CH ₃ CH ₃ 2-F-3-thienyl

109 CH(CH ₃ ) ₂ CH ₃ 5-CI-2-thienyl

1 10 C(CH ₃ )=CH ₂ CH ₃ 5-CI-2-thienyl

1 1 1 C(F)=CH ₂ CH ₃ 5-CI-2-thienyl

1 12 C(CH ₃ ) ₃ CH ₃ 5-CI-2-thienyl

1 13 CF ₃ CH ₃ 5-CI-2-thienyl

1 14 CH=CH ₂ CH ₃ 5-CI-2-thienyl

1 15 cyclopropyl CH ₃ 5-CI-2-thienyl

1 16 1 -methylcyclopropyl CH ₃ 5-CI-2-thienyl

1 17 1 -fluorocyclopropyl CH ₃ 5-CI-2-thienyl

1 18 1 -cyanocyclopropyl CH ₃ 5-CI-2-thienyl

1 19 CF(CH ₃ ) ₂ CH ₃ 5-CI-2-thienyl Entry R ₅ Re R ₇

120 CF2CH3 CH ₃ 5-CI-2-thienyl

121 CH(CH ₃ ) ₂ CH ₃ 5-CI-3-thienyl

122 C(CH ₃ )=CH ₂ CH ₃ 5-CI-3-thienyl

123 C(F)=CH ₂ CH ₃ 5-CI-3-thienyl

124 C(CH ₃ ) ₃ CH ₃ 5-CI-3-thienyl

125 CF ₃ CH ₃ 5-CI-3-thienyl

126 CH=CH ₂ CH ₃ 5-CI-3-thienyl

127 cyclopropyl CH ₃ 5-CI-3-thienyl

128 1 -methylcyclopropyl CH ₃ 5-CI-3-thienyl

129 1 -fluorocyclopropyl CH ₃ 5-CI-3-thienyl

130 1 -cyanocyclopropyl CH ₃ 5-CI-3-thienyl

131 CF(CH ₃ ) ₂ CH ₃ 5-CI-3-thienyl

132 CF ₂ CH ₃ CH ₃ 5-CI-3-thienyl

133 CH(CH ₃ ) ₂ CH ₃ 2-CI-3-thienyl

134 C(CH ₃ )=CH ₂ CH ₃ 2-CI-3-thienyl

135 C(F)=CH ₂ CH ₃ 2-CI-3-thienyl

136 C(CH ₃ ) ₃ CH ₃ 2-CI-3-thienyl

137 CF ₃ CH ₃ 2-CI-3-thienyl

138 CH=CH ₂ CH ₃ 2-CI-3-thienyl

139 cyclopropyl CH ₃ 2-CI-3-thienyl

140 1 -methylcyclopropyl CH ₃ 2-CI-3-thienyl

141 1 -fluorocyclopropyl CH ₃ 2-CI-3-thienyl

142 1 -cyanocyclopropyl CH ₃ 2-CI-3-thienyl

143 CF(CH ₃ ) ₂ CH ₃ 2-CI-3-thienyl

144 CF ₂ CH ₃ CH ₃ 2-CI-3-thienyl

145 CH(CH ₃ ) ₂ CH ₃ pyrazol-1 -yl

146 C(CH ₃ )=CH ₂ CH ₃ pyrazol-1 -yl

147 C(F)=CH ₂ CH ₃ pyrazol-1 -yl

148 C(CH ₃ ) ₃ CH ₃ pyrazol-1 -yl

149 CF ₃ CH ₃ pyrazol-1 -yl

150 CH=CH ₂ CH ₃ pyrazol-1 -yl

151 cyclopropyl CH ₃ pyrazol-1 -yl

152 1 -methylcyclopropyl CH ₃ pyrazol-1 -yl

153 1 -fluorocyclopropyl CH ₃ pyrazol-1 -yl

154 1 -cyanocyclopropyl CH ₃ pyrazol-1 -yl Entry R ₅ Re R ₇

155 CF(CH ₃ ) ₂ CH ₃ pyrazol-1 -yl

156 CF2CH3 CH ₃ pyrazol-1 -yl

157 CH(CH ₃ ) ₂ CH ₃ 3-CH ₃ -pyrazol-1 -yl

158 C(CH ₃ )=CH ₂ CH ₃ 3-CH ₃ -pyrazol-1 -yl

159 C(F)=CH ₂ CH ₃ 3-CH ₃ -pyrazol-1 -yl

160 C(CH ₃ ) ₃ CH ₃ 3-CH ₃ -pyrazol-1 -yl

161 CF ₃ CH ₃ 3-CH ₃ -pyrazol-1 -yl

162 CH=CH ₂ CH ₃ 3-CH ₃ -pyrazol-1 -yl

163 cyclopropyl CH ₃ 3-CH ₃ -pyrazol-1 -yl

164 1 -methylcyclopropyl CH ₃ 3-CH ₃ -pyrazol-1 -yl

165 1 -fluorocyclopropyl CH ₃ 3-CH ₃ -pyrazol-1 -yl

166 1 -cyanocyclopropyl CH ₃ 3-CH ₃ -pyrazol-1 -yl

167 CF(CH ₃ ) ₂ CH ₃ 3-CH ₃ -pyrazol-1 -yl

168 CF ₂ CH ₃ CH ₃ 3-CH ₃ -pyrazol-1 -yl

169 CH(CH ₃ ) ₂ CH ₃ thiazol-2-y

170 C(CH ₃ )=CH ₂ CH ₃ thiazol-2-y

171 C(F)=CH ₂ CH ₃ thiazol-2-y

172 C(CH ₃ ) ₃ CH ₃ thiazol-2-y

173 CF ₃ CH ₃ thiazol-2-y

174 CH=CH ₂ CH ₃ thiazol-2-y

175 cyclopropyl CH ₃ thiazol-2-y

176 1 -methylcyclopropyl CH ₃ thiazol-2-y

177 1 -fluorocyclopropyl CH ₃ thiazol-2-y

178 1 -cyanocyclopropyl CH ₃ thiazol-2-y

179 CF(CH ₃ ) ₂ CH ₃ thiazol-2-y

180 CF ₂ CH ₃ CH ₃ thiazol-2-y

181 CH(CH ₃ ) ₂ CH ₃ thiazol-4-y

182 C(CH ₃ )=CH ₂ CH ₃ thiazol-4-y

183 C(F)=CH ₂ CH ₃ thiazol-4-y

184 C(CH ₃ ) ₃ CH ₃ thiazol-4-y

185 CF ₃ CH ₃ thiazol-4-y

186 CH=CH ₂ CH ₃ thiazol-4-y

187 cyclopropyl CH ₃ thiazol-4-y

188 1 -methylcyclopropyl CH ₃ thiazol-4-y

189 1 -fluorocyclopropyl CH ₃ thiazol-4-y Entry R ₅ Re R ₇

190 1 -cyanocyclopropyl CH ₃ thiazol-4-yl

191 CF(CH ₃ ) ₂ CH ₃ thiazol-4-yl

192 CF2CH3 CH ₃ thiazol-4-yl

193 CH(CH ₃ ) ₂ CH ₃ thiazol-5-yl

194 C(CH ₃ )=CH ₂ CH ₃ thiazol-5-yl

195 C(F)=CH ₂ CH ₃ thiazol-5-yl

196 C(CH ₃ ) ₃ CH ₃ thiazol-5-yl

197 CF ₃ CH ₃ thiazol-5-yl

198 CH=CH ₂ CH ₃ thiazol-5-yl

199 cyclopropyl CH ₃ thiazol-5-yl

200 1 -methylcyclopropyl CH ₃ thiazol-5-yl

201 1 -fluorocyclopropyl CH ₃ thiazol-5-yl

202 1 -cyanocyclopropyl CH ₃ thiazol-5-yl

203 CF(CH ₃ ) ₂ CH ₃ thiazol-5-yl

204 CF ₂ CH ₃ CH ₃ thiazol-5-yl

205 CH(CH ₃ ) ₂ CH ₃ 2-CH ₃ -thiazol-4-y

206 C(CH ₃ )=CH ₂ CH ₃ 2-CH ₃ -thiazol-4-y

207 C(F)=CH ₂ CH ₃ 2-CH ₃ -thiazol-4-y

208 C(CH ₃ ) ₃ CH ₃ 2-CH ₃ -thiazol-4-y

209 CF ₃ CH ₃ 2-CH ₃ -thiazol-4-y

210 CH=CH ₂ CH ₃ 2-CH ₃ -thiazol-4-y

21 1 cyclopropyl CH ₃ 2-CH ₃ -thiazol-4-y

212 1 -methylcyclopropyl CH ₃ 2-CH ₃ -thiazol-4-y

213 1 -fluorocyclopropyl CH ₃ 2-CH ₃ -thiazol-4-y

214 1 -cyanocyclopropyl CH ₃ 2-CH ₃ -thiazol-4-y

215 CF(CH ₃ ) ₂ CH ₃ 2-CH ₃ -thiazol-4-y

216 CF ₂ CH ₃ CH ₃ 2-CH ₃ -thiazol-4-y

217 CH(CH ₃ ) ₂ CH ₃ 2-CH ₃ -thiazol-5-y

218 C(CH ₃ )=CH ₂ CH ₃ 2-CH ₃ -thiazol-5-y

219 C(F)=CH ₂ CH ₃ 2-CH ₃ -thiazol-5-y

220 C(CH ₃ ) ₃ CH ₃ 2-CH ₃ -thiazol-5-y

221 CF ₃ CH ₃ 2-CH ₃ -thiazol-5-y

222 CH=CH ₂ CH ₃ 2-CH ₃ -thiazol-5-y

223 cyclopropyl CH ₃ 2-CH ₃ -thiazol-5-y

224 1 -methylcyclopropyl CH ₃ 2-CH ₃ -thiazol-5-y Entry R ₅ Re R ₇

225 1 -fluorocyclopropyl CH ₃ 2-CH ₃ -thiazol-5-yl

226 1 -cyanocyclopropyl CH ₃ 2-CH ₃ -thiazol-5-yl

227 CF(CH ₃ ) ₂ CH ₃ 2-CH ₃ -thiazol-5-yl

228 CF2CH3 CH ₃ 2-CH ₃ -thiazol-5-yl

229 CH(CH ₃ ) ₂ CH ₃ 2-CI-thiazol-4-yl

230 C(CH ₃ )=CH ₂ CH ₃ 2-CI-thiazol-4-yl

231 C(F)=CH ₂ CH ₃ 2-CI-thiazol-4-yl

232 C(CH ₃ ) ₃ CH ₃ 2-CI-thiazol-4-yl

233 CFs CH ₃ 2-CI-thiazol-4-yl

234 CH=CH ₂ CH ₃ 2-CI-thiazol-4-yl

235 cyclopropyl CH ₃ 2-CI-thiazol-4-yl

236 1 -methylcyclopropyl CH ₃ 2-CI-thiazol-4-yl

237 1 -fluorocyclopropyl CH ₃ 2-CI-thiazol-4-yl

238 1 -cyanocyclopropyl CH ₃ 2-CI-thiazol-4-yl

239 CF(CH ₃ ) ₂ CH ₃ 2-CI-thiazol-4-yl

240 CF ₂ CH ₃ CH ₃ 2-CI-thiazol-4-yl

241 CH(CH ₃ ) ₂ CH ₃ 2-CI-thiazol-5-yl

242 C(CH ₃ )=CH ₂ CH ₃ 2-CI-thiazol-5-yl

243 C(F)=CH ₂ CH ₃ 2-CI-thiazol-5-yl

244 C(CH ₃ ) ₃ CH ₃ 2-CI-thiazol-5-yl

245 CF ₃ CH ₃ 2-CI-thiazol-5-yl

246 CH=CH ₂ CH ₃ 2-CI-thiazol-5-yl

247 cyclopropyl CH ₃ 2-CI-thiazol-5-yl

248 1 -methylcyclopropyl CH ₃ 2-CI-thiazol-5-yl

249 1 -fluorocyclopropyl CH ₃ 2-CI-thiazol-5-yl

250 1 -cyanocyclopropyl CH ₃ 2-CI-thiazol-5-yl

251 CF(CH ₃ ) ₂ CH ₃ 2-CI-thiazol-5-yl

252 CF ₂ CH ₃ CH ₃ 2-CI-thiazol-5-yl

253 CH(CH ₃ ) ₂ CH ₃ 3,3-d ifluoro-1 -azetidinyl

254 C(CH ₃ )=CH ₂ CH ₃ 3,3-d ifluoro-1 -azetidinyl

255 C(F)=CH ₂ CH ₃ 3, 3-d ifluoro-1 -azetidinyl

256 C(CH ₃ ) ₃ CH ₃ 3, 3-d ifluoro-1 -azetidinyl

257 CF ₃ CH ₃ 3, 3-d ifluoro-1 -azetidinyl

258 CH=CH ₂ CH ₃ 3, 3-d ifluoro-1 -azetidinyl

259 cyclopropyl CH ₃ 3, 3-d ifluoro-1 -azetidinyl Entry R ₅ Re R ₇

260 1 -methylcyclopropyl CH ₃ 3,3-d ifluoro-1 -azetidinyl

261 1 -fluorocyclopropyl CH ₃ 3,3-d ifluoro-1 -azetidinyl

262 1 -cyanocyclopropyl CH ₃ 3, 3-d ifluoro-1 -azetidinyl

263 CF(CH ₃ ) ₂ CH ₃ 3, 3-d ifluoro-1 -azetidinyl

264 CF2CH3 CH ₃ 3, 3-d ifluoro-1 -azetidinyl

265 CH(CH ₃ ) ₂ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

266 C(CH ₃ )=CH ₂ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

267 C(F)=CH ₂ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

268 C(CH ₃ ) ₃ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

269 CFs CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

270 CH=CH ₂ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

271 cyclopropyl CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

272 1 -methylcyclopropyl CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

273 1 -fluorocyclopropyl CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

274 1 -cyanocyclopropyl CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

275 CF(CH ₃ ) ₂ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

276 CF ₂ CH ₃ CH ₃ 3, 3-d ifluoro-1 -pyrrolidinyl

277 CH(CH ₃ ) ₂ CH ₃ 3, 3-d ifluoro-1 -piperidyl

278 C(CH ₃ )=CH ₂ CH ₃ 3, 3-d ifluoro-1 -piperidyl

279 C(F)=CH ₂ CH ₃ 3, 3-d ifluoro-1 -piperidyl

280 C(CH ₃ ) ₃ CH ₃ 3, 3-d ifluoro-1 -piperidyl

281 CF ₃ CH ₃ 3, 3-d ifluoro-1 -piperidyl

282 CH=CH ₂ CH ₃ 3, 3-d ifluoro-1 -piperidyl

283 cyclopropyl CH ₃ 3, 3-d ifluoro-1 -piperidyl

284 1 -methylcyclopropyl CH ₃ 3, 3-d ifluoro-1 -piperidyl

285 1 -fluorocyclopropyl CH ₃ 3, 3-d ifluoro-1 -piperidyl

286 1 -cyanocyclopropyl CH ₃ 3, 3-d ifluoro-1 -piperidyl

287 CF(CH ₃ ) ₂ CH ₃ 3, 3-d ifluoro-1 -piperidyl

288 CF ₂ CH ₃ CH ₃ 3, 3-d ifluoro-1 -piperidyl

289 CH(CH ₃ ) ₂ CH ₃ 4, 4-d ifluoro-1 -piperidyl

290 C(CH ₃ )=CH ₂ CH ₃ 4, 4-d ifluoro-1 -piperidyl

291 C(F)=CH ₂ CH ₃ 4, 4-d ifluoro-1 -piperidyl

292 C(CH ₃ ) ₃ CH ₃ 4, 4-d ifluoro-1 -piperidyl

293 CF ₃ CH ₃ 4, 4-d ifluoro-1 -piperidyl

294 CH=CH ₂ CH ₃ 4, 4-d ifluoro-1 -piperidyl Entry R ₅ Re R ₇

295 cyclopropyl CH ₃ 4,4-difluoro-1 -piperidyl

296 1 -methylcyclopropyl CH ₃ 4,4-difluoro-1 -piperidyl

297 1 -fluorocyclopropyl CH ₃ 4,4-difluoro-1 -piperidyl

298 1 -cyanocyclopropyl CH ₃ 4,4-difluoro-1 -piperidyl

299 CF(CH ₃ ) ₂ CH ₃ 4,4-difluoro-1 -piperidyl

300 CF2CH3 CH ₃ 4,4-difluoro-1 -piperidyl

301 CH(CH ₃ ) ₂ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

302 C(CH ₃ )=CH ₂ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

303 C(F)=CH ₂ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

304 C(CH ₃ ) ₃ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

305 CFs CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

306 CH=CH ₂ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

307 cyclopropyl CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

308 1 -methylcyclopropyl CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

309 1 -fluorocyclopropyl CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

310 1 -cyanocyclopropyl CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

31 1 CF(CH ₃ ) ₂ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

312 CF ₂ CH ₃ CH ₃ 4,5-dihydro-3H-pyridazin-2-yl

313 CH(CH ₃ ) ₂ CH ₃ oxazinan-2-yl

314 C(CH ₃ )=CH ₂ CH ₃ oxazinan-2-yl

315 C(F)=CH ₂ CH ₃ oxazinan-2-yl

316 C(CH ₃ ) ₃ CH ₃ oxazinan-2-yl

317 CF ₃ CH ₃ oxazinan-2-yl

318 CH=CH ₂ CH ₃ oxazinan-2-yl

319 cyclopropyl CH ₃ oxazinan-2-yl

320 1 -methylcyclopropyl CH ₃ oxazinan-2-yl

321 1 -fluorocyclopropyl CH ₃ oxazinan-2-yl

322 1 -cyanocyclopropyl CH ₃ oxazinan-2-yl

323 CF(CH ₃ ) ₂ CH ₃ oxazinan-2-yl

324 CF ₂ CH ₃ CH ₃ oxazinan-2-yl

Table A2 provides 324 compounds of formula (l-a) wherein Ri is CH ₃ and R ₂ , R ₃ and R ₄ are all H and wherein the values of R5, R6 and R7 are as defined in Table Z above.

Table A3 provides 324 compounds of formula (l-a) wherein Ri is F and R ₂ , R ₃ and R ₄ are all H and wherein the values of R5, R6 and R7 are as defined in Table Z above. Table A4 provides 324 compounds of formula (l-a) wherein Ri is CI and R2, R3 and R ₄ are all H and wherein the values of R5, R6 and R7 are as defined in Table Z above.

Table A5 provides 324 compounds of formula (l-a) wherein Ri is F, R2 IS F, Rs and R ₄ are both H and wherein the values of R5, R6 and R7 are as defined in Table Z above.

Table A6 provides 324 compounds of formula (l-a) wherein Ri is F, R2 is H, R3 is CH3 and R ₄ is H and wherein the values of R5, R6 and R7 are as defined in Table Z above..

Table A7 provides 324 compounds of formula (l-a) wherein Ri is F, R2 is H, R3 is H and R ₄ is CH3 and wherein the values of R5, R6 and R7 are as defined in Table Z above.

Table A8 provides 324 compounds of formula l-b)

(l-b)

wherein Ri is F, R2, Rs and R ₄ are all H and wherein the values of R5, R6 and R7 are as defined in Table Z above.

Compounds of the present invention can be made as shown in the following schemes, in which, unless otherwise stated, the definition of each variable is as defined above for a compound of formula (I).

A shown in scheme 1 , compounds of general formula (l-a) wherein Ri, R2, R3, R ₄ , R5, R6, R7 and A are as defined for compounds of formula (I) and X is O can be prepared by the reaction of compounds of formula (II), wherein Ri, R2, R3 and R ₄ are as defined for compounds of formula (I), with amines of formula (III) wherein R ₅ , R6, R7 and A are as defined for compounds of formula I).

Scheme 1

Among the various reported methods for this transformation, the most widely applied involve treatment of carboxylic acid (II) with an activating agent like thionyl chloride or an amide coupling reagent like dicyclohexylcarbodiimide in an inert organic solvent like tetrahydrofuran (THF) or dimethylformamide (DMF) and reaction with amine (III) in the presence of a catalyst like dimethylaminopyridine as described in Chem. Soc. Rev., 2009, 606-631 or Tetrahedron 2005, 10827-10852.

As shown in scheme 2, compounds of general formula (l-a), wherein X is O, can also be prepared by the reaction of compounds of formula (IV) and (V) in the presence of a

Bronsted acid like sulphuric acid or trifluoromethane sulfonic acid, in a solvent like

dichloromethane or acetic acid at temperatures between -20 °C and +50 °C as described in Eur. J. Or . Chem. 2015, 2727-2732 and Synthesis 2000, 1709-1712.

Alternatively, compounds of general formula (l-a), wherein X is O, can also be prepared by the reaction of compounds of formula (VI), wherein Hal is a halogen, mainly chloro, bromo or iodo, with amines of formula (III), carbon monoxide, a base like triethylamine or potassium carbonate and a suitably supported transitional metal catalyst like palladium in an inert organic solvent like 1 ,4-dioxane at a temperature between 20 °C and 1 10 °C as described in Org. Lett., 2014, 4296-4299 and references therein) and shown in scheme 3.

Scheme 3

Alternatively, compounds of general formula (l-a) wherein X is O can also be prepared by the reaction of organometallic compounds of formula (Via), wherein Y is Li or MgZ and Z is bromo or iodo, with isocyanates of formula (Ilia) in an inert organic solvent like diethyl ether or THF at temperatures between -78 °C and +40 °C as described in Angew. Chem. Int. Ed. 2012, 9173 -9175 and shown in scheme 4.

(VI) (Via) (Ilia)

Scheme 4 The preparation of organometallic compounds of formula (Via), wherein Y is Li or MgZ and Z is bromo or iodo, from compounds of formula (VI), wherein Hal is bromo or iodo, by lithium-halogen exchange with an alkyl lithium reagent like s-butyl lithium or magnesium- halogen exchange with tri n-butyl magnesate in an ethereal solvent like THF at temperatures between -90 °C and +20 °C is generally known to a person skilled in the art, and is described in synthetic chemistry texts such as March's Advanced Organic Chemistry.

As shown in scheme 5, carboxylic acids of formula (II) can be prepared by various methods and many are commercially available. Among the many reported methods for their preparation, the following have been widely applied:

Scheme 5

1 ) Transformation of anilines of formula (VII) to quinolones of formula (VI lb), wherein Rio is C1 -C6 alkyl, by reaction with a malonate derivative of formula (Vila) in an inert solvent like diphenyl ether at temperatures between 100 °C and 260°C as described in US

20070015758, followed by well-known functional group interconversion which is generally known to a person skilled in the art and also described in WO 2007133637.

2) Transformation of compounds of formula (VI) to organometallic intermediates of formula (Via), wherein Y is Li or MgZ and Z is bromo or iodo, by lithium-halogen exchange with an alkyl lithium reagent like s-butyl lithium or magnesium-halogen exchange with tri n- butyl magnesate in an ethereal solvent like THF at temperatures between -90 °C and +20 °C and subsequent reaction with CO2.

3) Transformation of compounds of formula (VI), wherein Hal is halogen, mainly chloro, bromo or iodo, in the presence of a carbon monoxide source, a base like triethylamine, water or an equivalent thereof and a suitably ligated transition metal catalyst containing for example palladium as described in J. Am. Chem. Soc. 2013, 2891 -2894 (and references therein) or

Tetrahedron 2003, 8629-8640.

As shown in scheme 6, compounds of formula (IV) can be prepared from compounds of formula (VI), wherein Hal is halogen, by treatment with a cyanide source like zinc cyanide in the presence of a palladium, nickel or copper catalyst in an inert solvent like DMF at temperatures between 20 °C and 150 °C as described in J. Org. Chem. 2011 , 665-668 or Bull.

Chem. Soc. Jpn. 1993, 2776-8.

(VI) (IV)

Scheme 6

As shown in scheme 7, compounds of formula (VI), wherein Hal is halogen, can be prepared by treatment of compounds of formula (Via) with a halogenating agent like N- iodosuccinimide, bromine or chlorine in an inert solvent as described in WO 20051 13539 or JP 2001322979. Alternatively, compounds of formula (VI) can be prepared by treatment of propargylated anilines of formula (VIb) with a halogenating agent like iodine in an inert solvent like acetonitrile and a base like sodium hydrogen carbonate at temperatures between 0 °C and 80 °C as described in Or . Lett. 2005, 763-766.

Scheme 7.

The preparation of propargylated anilines of formula (VIb) from the corresponding commercially available anilines is trivial to a person skilled in the art and described in March's Advanced Organic Chemistry, Smith and March, 6 ^th edition, Wiley, 2007.

The synthesis of compounds of formula (Via) is generally known to a person skilled in the art and a large selection of compounds is commercially available.

As shown in scheme 8, compounds of formula (V) can be prepared from carbonyl compounds of formula (Va), (Vb) or (Vc) by treatment with an organometallic species of formula (Vd), (Ve) or (Vf), respectively, wherein M is lithium, an aluminum- or a magnesium- salt, in an inert solvent like diethyl ether at temperatures between -90 °C and 60 °C.

(Vc) (Vf)

Scheme 8

The general preparation, handling and reactivity of reagents with formula (Vd), (Ve) and (Vf) is described in March's Advanced Organic Chemistry, Smith and March, 6 ^th edition, Wiley, 2007 and is generally known to a person skilled in the art. A large selection of compounds of formula (Va), (Vb) and (Vc), where Rs, R6 and R7 as defined in the above, are also commercially available and their syntheses are well described in the scientific literature and synthetic chemistry text (such as March's Advanced Organic Chemistry) and, further, are generally known to a person skilled in the art.

As shown in scheme 9, amines of formula (III) can be prepared from compounds of formula (Va), (Vb) and (Vc) by condensation with tertbutyl sulfinamide in the presence of a dehydrating agent like Ti(OEt) ₄ to form sulfimines of formula (Vg), (Vh) and (Vi) which can then be treated with an organometallic reagent of formula (Vd), (Ve) and (Vf), wherein M is lithium, an aluminum- or a magnesium-salt, in an inert solvent like THF at temperatures between -78 °C and + 70 °C, followed by an acidic hydrolysis of the sulfinamide; a sequence generally known to a person skilled in the art and also described in Chem. Rev. 2010, 3600-3740.

Scheme 9

Alternatively, amines of formula (III) can be also prepared from alcohols of formula (V) by treatment with a strong acid like sulfuric acid in the presence of chloroacetonitrile in an organic solvent like acetic acid at temperatures between -10 °C and 50 °C to give amides of formula (1Mb) which can be deprotected with thiourea in an organic solvent like ethanol or acetic acid at temperatures between 20 °C and 100 °C as described in Synthesis 2000, 1709 - 1712 and shown in scheme 10.

(III)

(1Mb) (III)

Scheme 10

Alternatively, amines of formula (III) can be also prepared from carboxylic acids of formula (IXa) through an intermediary isocyanate of formula (Ilia) or a carbamate of formula (III c), where Rn is C1-C4 alkyl or CHsOPhChb, which can be hydrolyzed with aqueous acid or base at temperatures between 0 °C and 100 °C as shown in scheme 1 1.

(IXb)

Scheme 1 1

Among the various protocols reported for the transformation of acid (IX) to isocyanate (Ilia), the following have found wide spread application:

1 ) Treatment of acid (IXa) with diphenylphosphoryl azide and an amine base like tributylamine in an inert organic solvent like toluene at temperatures between 50 °C and 120 °C to give isocyanate (Ilia) as described in Aust. J. Chem., 1973, 1591 -3.

2) Treatment of acid (IXa) with an activating agent like thionyl chloride or

propylphosphonic anhydride in the presence of an azide source like sodium azide and an amine base like triethyl amine in an inert solvent like THF at temperatures between 20 °C and 100 °C as described in Synthesis 201 1 , 1477-1483.

3) Conversion of acid (IXa) to the corresponding hydroxamic acids which can then be treated with a dehydrating agent like para-toluenesulfonyl chloride and a base like

triethylamine in an inert organic solvent like toluene at temperatures between 20 °C and 120 °C.

4) Conversion of acid (IXa) to the corresponding primary carboxamide (IXb) which can then be treated with an oxidizing agent such as diacetoxyiodobenzene and an acid such as trifluoroacetic acid or para-toluenesulfonic acid in a solvent like acetonitrile at temperatures between 0 °C and 100 °C as described in J. Org. Chem. 1984, 4212-4216.

5) Conversion of acid (IXa) to the corresponding primary carboxamide (IXb) which can then be treated with an oxidizing agent such as bromine and a base such as sodium hydroxide in a solvent like water or methanol at temperatures between 0 °C and 100 °C.

A person skilled in the art will appreciate that carboxylic acids of formula (IXa) can be prepared from the corresponding esters. Similarly a person skilled in the art will appreciate that the alpha position of these esters can be functionalized by deprotonation with a strong base like lithium diisopropylamine in an inert solvent like THF at temperatures between -78 °C and 20 °C followed by reaction with an electrophilic reagent like an alkyl iodide as described in March's Advanced Organic Chemistry, Smith and March, 6 ^th edition, Wiley, 2007. This reaction can be repeated and the introduced alkyl, alkenyl and alkynyl groups can be further functionalized by halogenation, cyclopropanation, oxidation or reduction, cross coupling (eg Sonogashira coupling) to prepare acid derivatives of formula (IXa) and (IXb) from

commercially available esters.

5 Alternatively, certain amines of formula (ll lc) can be prepared from olefins of formula

(Xa) by treatment with sodium trifluoromethyl sulfinate, an aryl diazonium salt such as benzenediazonium fluoroborate and a catalyst such as silver nitrate, followed by reduction of the resulting azo compounds of formula (XI) with raney nickel under a hydrogen atmosphere in a solvent such as ethanol at temperatures between 0 °C and 100 °C. This is shown in scheme 10 12.

Scheme 12

Alternatively, amines of formula (ll ld) can be also prepared by the sequences shown in scheme 13:

1 ) Reduction of amino acids of formula (Xllc) with a reducing agent such as LiAII-U in an inert solvent like THF to form amino alcohols of formula (Xllb), followed by sulfonylation, ring closure to an aziridine of formula (Xlla), ring opening of the aziridine with R12R13NH (XI I I), wherein Ri2Ri3 taken together form a C4-C6 saturated or partially unsaturated heterocycles or heteroaryls, with an inorganic base such as potassium carbonate in a solvent such as DMF at rt or with heating, and finally removal of the sulfonyl group.

2) Aziridination of olefins of formula (Xb) to form aziridines of formula (Xlla) with

sulfonamides, an oxidizing agent and a rhodium catalyst as described in Org. Lett., 2005, 2787-2790, followed by ring opening of the aziridine with R12R13NH (XI II) and removal of the sulfonyl group as described in the section above.

(Xllc) (Xllb) (Mid)

(Xlla)

Scheme 13

A large selection of amino acids of formula (Xl lc) and olefins of formula (Xa) and (Xb) are commercially available and general protocols for their preparation has been reported in the chemical literature and are known to a person skilled in the art.

Alternatively, amines of formula (I I I) can be also prepared by treatment of compounds of formula (V) with trimethylsilyl azide and a lewis acid catalyst like B(CeF6)3 in an inert solvent like toluene at temperatures between 0 °C and 100 °C as described in J. Am. Chem. Soc. 2015, 9555-9558, followed by reduction of the intermediary azides of formula (XIV) with a reducing agent like hydrogen/palladium in an organic solvent like methanol at temperatures between 0 °C and 80°C as shown as shown in scheme 14.

(V) (XIV) (III)

Scheme 14

As shown in scheme 15, compounds of general formula (l-b) wherein X is S can be prepared from compounds of general formula (l-a) wherein X is O by treatment with a deoxothionating agent like P4Sio or Lawesson reagent in an inert organic solvent like toluene at temperatures between 20 °C and 150 °C.

Scheme 15

Alternatively, the compounds of formula (l-a) wherein Ri , R2, R3, R ₄ , R5, Re and R7 are as defined for compounds of formula (I) and X is O, can be obtained by transformation of another, closely related, compound of formula (l-a) using standard synthesis techniques known to the person skilled in the art. Non-exhaustive examples include oxidation reactions, reduction reactions, hydrolysis reactions, coupling reactions, aromatic nucleophilic or electrophilic substitution reactions, nucleophilic substitution reactions, nucleophilic addition reactions, and halogenation reactions.

Certain intermediates described in the above schemes are novel and as such form a further aspect of the invention.

The compounds of formula (I) can be used in the agricultural sector and related fields of use e.g. as active ingredients for controlling plant pests or on non-living materials for control of spoilage microorganisms or organisms potentially harmful to man. The novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and may be used for protecting numerous cultivated plants. The compounds of formula (I) can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms.

It is also possible to use compounds of formula (I) as fungicide. The term "fungicide" as used herein means a compound that controls, modifies, or prevents the growth of fungi. The term "fungicidally effective amount" means the quantity of such a compound or combination of such compounds that is capable of producing an effect on the growth of fungi. Controlling or modifying effects include all deviation from natural development, such as killing, retardation and the like, and prevention includes barrier or other defensive formation in or on a plant to prevent fungal infection.

It is also possible to use compounds of formula (I) as dressing agents for the treatment of plant propagation material, e.g., seed, such as fruits, tubers or grains, or plant cuttings (for example rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula (I) before planting: seed, for example, can be dressed before being sown. The compounds of formula (I) can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied to the planting site when the propagation material is being planted, for example, to the seed furrow during sowing. The invention relates also to such methods of treating plant propagation material and to the plant propagation material so treated.

Furthermore the compounds according to present invention can be used for controlling fungi in related areas, for example in the protection of technical materials, including wood and wood related technical products, in food storage, in hygiene

management.

In addition, the invention could be used to protect non-living materials from fungal attack, e.g. lumber, wall boards and paint.

Compounds of formula (I) and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens. They are effective in controlling a broad spectrum of plant diseases, such as foliar pathogens of ornamental, turf, vegetable, field, cereal, and fruit crops.

These fungi and fungal vectors of disease, as well as phytopathogenic bacteria and viruses, which may be controlled are for example:

Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. inclusing B. cinerea, Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C.

arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea,

Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae,

Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp,

Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp. including H. capsulatum, Laetisaria fuciformis,

Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp,

Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. Including P. maydis, P. philippinensis and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp,

Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T.

pseudokoningii, T. viride,

Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V. inaequalis, Verticillium spp, and Xanthomonas spp.

In particular, compounds of formula (I) and fungicidal compositions containing them may be used to control plant diseases caused by a broad spectrum of fungal plant pathogens in the Basidiomycete, Ascomycete, Oomycete and/or Deuteromycete, Blasocladiomycete, Chrytidiomycete, Glomeromycete and/or Mucoromycete classes.

These pathogens may include:

Oomycetes, including Phytophthora diseases such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora and Phytophthora erythroseptica; Pythium diseases such as those caused by Pythium

aphanidermatum, Pythium arrhenomanes, Pythium graminicola, Pythium irregulare and Pythium ultimum; diseases caused by Peronosporales such as Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubensis, Albugo Candida, Sclerophthora macrospora and Bremia lactucae; and others such as Aphanomyces cochlioides, Labyrinthula zosterae, Peronosclerospora sorghi and

Sclerospora graminicola.

Ascomycetes, including blotch, spot, blast or blight diseases and/or rots for example those caused by Pleosporales such as Stemphylium solani, Stagonospora tainanensis, Spilocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii,

Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporium triticirepentis, Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus, Bipolaris cactivora, Venturia inaequalis, Pyrenophora teres, Pyrenophora tritici-repentis, Alternaria alternata, Alternaria brassicicola, Alternaria solani and Alternaria tomatophila, Capnodiales such as Septoria tritici, Septoria nodorum, Septoria glycines, Cercospora arachidicola, Cercospora sojina, Cercospora zeae-maydis, Cercosporella capsellae and Cercosporella herpotrichoides, Cladosporium carpophilum, Cladosporium effusum,

Passalora fulva, Cladosporium oxysporum, Dothistroma septosporum, Isariopsis clavispora, Mycosphaerella fijiensis, Mycosphaerella graminicola, Mycovellosiella koepkeii,

Phaeoisariopsis bataticola, Pseudocercospora vitis, Pseudocercosporella herpotrichoides, Ramularia beticola, Ramularia collo-cygni, Magnaporthales such as Gaeumannomyces graminis, Magnaporthe grisea, Pyricularia oryzae, Diaporthales such as Anisogramma anomala, Apiognomonia errabunda, Cytospora platani, Diaporthe phaseolorum, Discula destructiva, Gnomonia fructicola, Greeneria uvicola, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-juglandacearum, Tubakia dryina, Dicarpella spp., Valsa ceratosperma, and others such as Actinothyrium graminis, Ascochyta pisi, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Asperisporium caricae, Blumeriella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Epicoccum nigrum, Epidermophyton spp., Eutypa lata, Geotrichum candidum, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans; Gloeotinia temulenta, Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola,

Microdochium nivale, Monilinia fructicola, Monographella albescens, Monosporascus cannonballus, Naemacyclus spp., Ophiostoma novo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri, Petriellidium spp., Pezicula spp., Phialophora gregata, Phyllachora pomigena, Phymatotrichum omnivora, Physalospora abdita,

Plectosporium tabacinum, Polyscytalum pustulans, Pseudopeziza medicaginis,

Pyrenopeziza brassicae, Ramulispora sorghi, Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomi, Sclerotinia sclerotiorum, Sclerotinia minor, Sclerotium spp., Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonema phacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina bullata, Thielviopsis basicola, Trichoseptoria fructigena, Zygophiala jamaicensis; powdery mildew diseases for example those caused by Erysiphales such as Blumeria graminis, Erysiphe polygoni, Uncinula necator, Sphaerotheca fuligena, Podosphaera leucotricha, Podospaera macularis

Golovinomyces cichoracearum, Leveillula taurica, Microsphaera diffusa, Oidiopsis gossypii, Phyllactinia guttata and Oidium arachidis; molds for example those caused by

Botryosphaeriales such as Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia fabae, Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Macrophomina phaseolina, Phyllosticta

cucurbitacearum; anthracnoses for example those caused by Glommerelales such as Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii,

Glomerella cingulata, and Colletotrichum graminicola; and wilts or blights for example those caused by Hypocreales such as Acremonium strictum, Claviceps purpurea, Fusarium culmorum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusarium subglutinans, Fusarium oxysporum f.sp. cubense, Gerlachia nivale, Gibberella fujikuroi, Gibberella zeae, Gliocladium spp., Myrothecium verrucaria, Nectria ramulariae, Trichoderma viride, Trichothecium roseum, and Verticillium theobromae.

Basidiomycetes, including smuts for example those caused by Ustilaginales such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts for example those caused by Pucciniales such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia stri if orm i s sp. Hordei, Puccinia striiformis f.sp. Secalis, Pucciniastrum coryli, or Uredinales such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other rots and diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata, Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma dahliae, Entylomella microspora, Neovossia moliniae and Tilletia caries.

Blastocladiomycetes, such as Physoderma maydis.

Mucoromycetes, such as Choanephora cucurbitarum.; Mucor spp.; Rhizopus arrhizus,

As well as diseases caused by other species and genera closely related to those listed above.

In addition to their fungicidal activity, the compounds and compositions comprising them may also have activity against bacteria such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Strptomyces scabies and other related species as well as certain protozoa.

Within the scope of present invention, target crops and/or useful plants to be protected typically comprise perennial and annual crops, such as berry plants for example 5 blackberries, blueberries, cranberries, raspberries and strawberries; cereals for example barley, maize (corn), millet, oats, rice, rye, sorghum triticale and wheat; fibre plants for example cotton, flax, hemp, jute and sisal; field crops for example sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees for example apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear

10 and plum; grasses for example Bermuda grass, bluegrass, bentgrass, centipede grass,

fescue, ryegrass, St. Augustine grass and Zoysia grass; herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes for example beans, lentils, peas and soya beans; nuts for example almond, cashew, ground nut, hazelnut, peanut, pecan, pistachio and walnut; palms for example oil palm; ornamentals for

15 example flowers, shrubs and trees; other trees, for example cacao, coconut, olive and

rubber; vegetables for example asparagus, aubergine, broccoli, cabbage, carrot, cucumber, garlic, lettuce, marrow, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and vines for example grapes.

The useful plants and / or target crops in accordance with the invention include

20 conventional as well as genetically enhanced or engineered varieties such as, for example, insect resistant (e.g. Bt. and VIP varieties) as well as disease resistant, herbicide tolerant (e.g. glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode tolerant varieties. By way of example, suitable genetically enhanced or engineered crop varieties include the Stoneville

25 5599BR cotton and Stoneville 4892BR cotton varieties.

The term "useful plants" and/or "target crops" is to be understood as including also useful plants that have been rendered tolerant to herbicides like bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyrovyl-shikimate-3-phosphate-synthase)

30 inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase)

inhibitors) as a result of conventional methods of breeding or genetic engineering. An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding (mutagenesis) is Clearfield® summer rape (Canola).

Examples of crops that have been rendered tolerant to herbicides or classes of herbicides by

35 genetic engineering methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady® , Herculex I® and

LibertyLink®. The term "useful plants" and/or "target crops" is to be understood as including those which naturally are or have been rendered resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to be capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria. Examples of toxins which can be expressed include δ-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins of bacteria colonising nematodes, and toxins produced by scorpions, arachnids, wasps and fungi. An example of a crop that has been modified to express the Bacillus thuringiensis toxin is the Bt maize KnockOut® (Syngenta Seeds). An example of a crop comprising more than one gene that codes for insecticidal resistance and thus expresses more than one toxin is VipCot® (Syngenta Seeds). Crops or seed material thereof can also be resistant to multiple types of pests (so- called stacked transgenic events when created by genetic modification). For example, a plant can have the ability to express an insecticidal protein while at the same time being herbicide tolerant, for example Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).

The term "useful plants" and/or "target crops" is to be understood as including also useful plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818, and EP-A-0 353 191 . The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.

Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect- specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors;

ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP- glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.

Further, in the context of the present invention there are to be understood by δ- endotoxins, for example CrylAb, CrylAc, Cry1 F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see

WO03/018810).

More examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO93/07278, W095/34656, EP-A-0 427 529, EP-A-451 878 and WO03/052073.

The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651 .

The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).

Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a CrylAc toxin); Bollgard II® (cotton variety that expresses a CrylAc and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin); NewLeaf® (potato variety that expresses a Cry3A toxin);

NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer (CB) trait) and Protecta®. Further examples of such transgenic crops are:

1 . Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St.

Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1 Ab toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St.

Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.

4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B- 1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.

5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/ES/96/02.

6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1 F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.

7. NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 x MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer. The term "locus" as used herein means fields in or on which plants are growing, or where seeds of cultivated plants are sown, or where seed will be placed into the soil. It includes soil, seeds, and seedlings, as well as established vegetation.

The term "plants" refers to all physical parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, stalks, foliage, and fruits.

The term "plant propagation material" is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example potatoes. There may be mentioned for example seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and parts of plants. Germinated plants and young plants which are to be transplanted after germination or after emergence from the soil, may also be mentioned. These young plants may be protected before transplantation by a total or partial treatment by immersion. Preferably "plant propagation material" is understood to denote seeds.

Pesticidal agents referred to herein using their common name are known, for example, from "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009.

The compounds of formula (I) may be used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they may be conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances. As with the type of the compositions, the methods of application, such as spraying, atomising, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances. The compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.

Suitable carriers and adjuvants, e.g. for agricultural use, can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers. Such carriers are for example described in WO 97/33890.

Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. Such formulations include anti-settling agents and dispersing agents and may further include a wetting agent to enhance activity as well an anti-foam and a crystal growth inhibitor. In use, these concentrates are diluted in water and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate. Wettable powders are in the form of finely divided particles which disperse readily in water or other liquid carriers. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include fuller's earth, kaolin clays, silicas and other readily wet organic or inorganic solids. Wettable powders normally contain from 5% to 95% of the active ingredient plus a small amount of wetting, dispersing or emulsifying agent.

Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or other liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent, or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or other liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may range from 0.5% to 95% of the concentrate.

Granular formulations include both extrudates and relatively coarse particles and are usually applied without dilution to the area in which treatment is required. Typical carriers for granular formulations include sand, fuller's earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, kaolin, dolomite, plaster, wood flour, ground corn cobs, ground peanut hulls, sugars, sodium chloride, sodium sulphate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulphate and other organic or inorganic materials which absorb or which can be coated with the active compound. Granular formulations normally contain 5% to 25% of active ingredients which may include surface-active agents such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and/or stickers such as dextrins, glue or synthetic resins.

Dusts are free-flowing admixtures of the active ingredient with finely divided solids such as talc, clays, flours and other organic and inorganic solids which act as dispersants and carriers.

Microcapsules are typically droplets or granules of the active ingredient enclosed in an inert porous shell which allows escape of the enclosed material to the surroundings at controlled rates. Encapsulated droplets are typically 1 to 50 microns in diameter. The enclosed liquid typically constitutes 50 to 95% of the weight of the capsule and may include solvent in addition to the active compound. Encapsulated granules are generally porous granules with porous membranes sealing the granule pore openings, retaining the active species in liquid form inside the granule pores. Granules typically range from 1 millimetre to 1 centimetre and preferably 1 to 2 millimetres in diameter. Granules are formed by extrusion, agglomeration or prilling, or are naturally occurring. Examples of such materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene- butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes and starch xanthates.

Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired

concentration, such as acetone, alkylated naphthalenes, xylene and other organic solvents. Pressurised sprayers, wherein the active ingredient is dispersed in finely-divided form as a result of vaporisation of a low boiling dispersant solvent carrier, may also be used.

Suitable agricultural adjuvants and carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.

Liquid carriers that can be employed include, for example, water, toluene, xylene, petroleum naphtha, crop oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetonalcohol, 1 ,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, Ν,Ν-dimethyl formamide, dimethyl sulfoxide, 1 ,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethyl hexanol, ethylene carbonate, 1 ,1 ,1 -trichloroethane, 2-heptanone, alpha pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropyl benzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octyl amine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monomethyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylene sulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol, and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerine and N-methyl-2-pyrrolidinone. Water is generally the carrier of choice for the dilution of concentrates.

Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaxeous earth, lime, calcium carbonate, bentonite clay, fuller's earth, cotton seed hulls, wheat flour, soybean flour, pumice, wood flour, walnut shell flour and lignin. A broad range of surface-active agents are advantageously employed in both said liquid and solid compositions, especially those designed to be diluted with carrier before application. These agents, when used, normally comprise from 0.1 % to 15% by weight of the formulation. They can be anionic, cationic, non-ionic or polymeric in character and can be employed as emulsifying agents, wetting agents, suspending agents or for other purposes. Typical surface active agents include salts of alkyl sulfates, such as

diethanolammonium lauryl sulphate; alkylarylsulfonate salts, such as calcium

dodecylbenzenesulfonate; alkylphenol-alkylene oxide addition products, such as

nonylphenol-C.sub. 18 ethoxylate; alcohol-alkylene oxide addition products, such as tridecyl alcohol-C.sub. 16 ethoxylate; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl) sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryl trimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono and dialkyl phosphate esters.

Other adjuvants commonly utilized in agricultural compositions include crystallisation inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, anti-foaming agents, light-blocking agents, compatibilizing agents, antifoam agents, sequestering agents, neutralising agents and buffers, corrosion inhibitors, dyes, odorants, spreading agents, penetration aids, micronutrients, emollients, lubricants and sticking agents.

In addition, further, other biocidally active ingredients or compositions may be combined with the compositions of the invention and used in the methods of the invention and applied simultaneously or sequentially with the compositions of the invention. When applied simultaneously, these further active ingredients may be formulated together with the compositions of the invention or mixed in, for example, the spray tank. These further biocidally active ingredients may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides and/or plant growth regulators.

In addition, the compositions of the invention may also be applied with one or more systemically acquired resistance inducers ("SAR" inducer). SAR inducers are known and described in, for example, United States Patent No. US 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.

The compounds of formula (I) are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds. These further compounds can be e.g. fertilizers or micronutrient donors or other preparations, which influence the growth of plants. They can also be selective herbicides or non-selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.

The compounds of formula (I) may be used in the form of (fungicidal) compositions for controlling or protecting against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) or of at least one preferred individual compound as above-defined, in free form or in agrochemically usable salt form, and at least one of the above-mentioned adjuvants.

The invention therefore provides a composition, preferably a fungicidal composition, comprising at least one compound formula (I) an agriculturally acceptable carrier and optionally an adjuvant. An agricultural acceptable carrier is for example a carrier that is suitable for agricultural use. Agricultural carriers are well known in the art. Preferably said composition may comprise at least one or more pesticidally active compounds, for example an additional fungicidal active ingredient in addition to the compound of formula (I).

The compound of formula (I) may be the sole active ingredient of a composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may, in some cases, result in unexpected synergistic activities.

Examples of suitable additional active ingredients include the following: 1 ,2,4- thiadiazoles, 2,6-dinitroanilines, acylalanines, aliphatic nitrogenous compounds, amidines, aminopyrimidinols, anilides, anilino-pyrimidines, anthraquinones, antibiotics, aryl- phenylketones, benzamides, benzene-sulfonamides, benzimidazoles, benzothiazoles, benzothiodiazoles, benzothiophenes, benzoylpyridines, benzthiadiazoles, benzylcarbamates, butylamines, carbamates, carboxamides, carpropamids, chloronitriles, cinnamic acid amides, copper containing compounds, cyanoacetamideoximes, cyanoacrylates, cyanoimidazoles, cyanomethylene-thiazolidines, dicarbonitriles, dicarboxamides, dicarboximides,

dimethylsulphamates, dinitrophenol carbonates, dinitrophenysl, dinitrophenyl crotonates, diphenyl phosphates, dithiino compounds, dithiocarbamates, dithioethers, dithiolanes, ethyl- amino-thiazole carboxamides, ethyl-phosphonates, furan carboxamides, glucopyranosyls, glucopyranoxyls, glutaronitriles, guanidines, herbicides/plant growth regulatosr,

hexopyranosyl antibiotics, hydroxy(2-amino)pyrimidines, hydroxyanilides, hydroxyisoxazoles, imidazoles, imidazolinones, insecticides/plant growth regulators, isobenzofuranones, isoxazolidinyl-pyridines, isoxazolines, maleimides, mandelic acid amides, mectin derivatives, morpholines, norpholines, n-phenyl carbamates, organotin compounds, oxathiin

carboxamides, oxazoles, oxazolidine-diones, phenols, phenoxy quinolines, phenyl- acetamides, phenylamides, phenylbenzamides, phenyl-oxo-ethyl-thiophenes amides, phenylpyrroles, phenylureas, phosphorothiolates, phosphorus acids, phthalamic acids, phthalimides, picolinamides, piperazines, piperidines, plant extracts, polyoxins,

propionamides, pthalimides, pyrazole-4-carboxamides, pyrazolinones, pyridazinones, pyridines, pyridine carboxamides, pyridinyl-ethyl benzamides, pyrimdinamines, pyrimidines, pyrimidine-amines, pyrimidione-hydrazone, pyrrolidines, pyrrolquinoliones, quinazolinones, quinolines, quinoline derivatives, quinoline-7-carboxylic acids, quinoxalines,

spiroketalamines, strobilurins, sulfamoyl triazoles, sulphamides, tetrazolyloximes, thiadiazines, thiadiazole carboxamides, thiazole carboxanides, thiocyanates, thiophene carboxamides, toluamides, triazines, triazobenthiazoles, triazoles, triazole-thiones, triazolo- pyrimidylamine, valinamide carbamates, ammonium methyl phosphonates, arsenic- containing compounds, benyimidazolylcarbamates, carbonitriles, carboxanilides,

carboximidamides, carboxylic phenylamides, diphenyl pyridines, furanilides, hydrazine carboxamides, imidazoline acetates, isophthalates, isoxazolones, mercury salts,

organomercury compounds, organophosphates, oxazolidinediones, pentylsulfonyl benzenes, phenyl benzamides, phosphonothionates, phosphorothioates, pyridyl carboxamides, pyridyl furfuryl ethers, pyridyl methyl ethers, SDHIs, thiadiazinanethiones, thiazolidines..

Examples of suitable additional active ingredients also include the following: 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4- tetrahydro-1 ,4-methano-naphthalen-5-yl)-amide, 3-difluoromethyl-1 -methyl-1 H-pyrazole-4- carboxylic acid methoxy-[1 -methyl-2-(2,4,6-trichlorophenyl)-ethyl]-amide, 1 -methyl-3- difluoromethyl-1 H-pyrazole-4-carboxylic acid (2-dichloromethylene-3-ethyl-1 -methyl-indan-4- yl)-amide (1072957-71 -1 ), 1 -methyl-3-difluoromethyl-1 H-pyrazole-4-carboxylic acid (4'- methylsulfanyl-biphenyl-2-yl)-amide, 1 -methyl-3-difluoromethyl-4H-pyrazole-4-carboxylic acid [2-(2,4-dichloro-phenyl)-2-methoxy-1 -methyl-ethyl]-amide, (5-Chloro-2,4-dimethyl-pyridin-3- yl)-(2,3,4-trimethoxy-6-methyl-phenyl)-methanone, (5-Bromo-4-chloro-2-methoxy-pyridin-3- yl)-(2,3,4-trimethoxy-6-methyl-phenyl)-methanone, 2-{2-[(E)-3-(2,6-Dichloro-phenyl)-1 - methyl-prop-2-en-(E)-ylideneaminooxymethyl]-phenyl}-2-[(Z)-m ethoxyimino]-N-methyl- acetamide, 3-[5-(4-Chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyrid ine, (E)-N-methyl-2- [2- (2, 5-dimethylphenoxymethyl) phenyl]-2-methoxy-iminoacetamide, 4-bromo-2-cyano-N, N-dimethyl-6-trifluoromethylbenzimidazole-1 -sulphonamide, o[N-(3-chloro-2,6-xylyl)-2- methoxyacetamido]-y-butyrolactone, 4-chloro-2-cyano-N,N - dimethyl-5-p-tolylimidazole-1 - sulfonamide, N-allyl-4, 5,-dimethyl-2-trimethylsilylthiophene-3-carboxamide, N- (l-cyano-1 , 2- dimethylpropyl)-2- (2, 4-dichlorophenoxy) propionamide, N- (2-methoxy-5-pyridyl)- cyclopropane carboxamide, (.+-.)-cis-1 -(4-chlorophenyl)-2-(1 H-1 ,2,4-triazol-1 -yl)- cycloheptanol, 2-(1 -ie/f-butyl)-1 -(2-chlorophenyl)-3-(1 ,2,4-triazol-1 -yl)-propan-2-ol, 2',6'- dibromo-2-methyl-4-trifluoromethoxy-4'-trifluoromethyl-1 ,3-thiazole- 5-carboxanilide, 1 - imidazolyl-1 -(4'-chlorophenoxy)-3,3-dimethylbutan-2-one, methyl (E)-2-[2-[6-(2- cyanophenoxy)pyrimidin-4-yloxy]phenyl]3-methoxyacrylate, methyl (E)-2-[2-[6-(2- thioamidophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate , methyl (E)-2-[2-[6-(2- fluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[6-(2,6- difluorophenoxy)pyrimidin-4-yloxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(pyrimidin-2- yloxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(5-methylpyrimidin-2-yloxy)- phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(phenyl- sulphonyloxy)phenoxy]phenyl-3-methoxyacrylate, methyl (E)-2-[2-[3-(4- nitrophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-phenoxyphenyl]-3- methoxyacrylate, methyl (E)-2-[2-(3,5-dimethyl-benzoyl)pyrrol-1 -yl]-3-methoxyacrylate, methyl (E)-2-[2-(3-methoxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2[2-(2- phenylethen-1 -yl)-phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3,5-dichlorophenoxy)pyridin-3- yl]-3-methoxyacrylate, methyl (E)-2-(2-(3-(1 ,1 ,2,2-tetrafluoroethoxy)phenoxy)phenyl)-3- methoxyacrylate, methyl (E)-2-(2-[3-(alpha-hydroxybenzyl)phenoxy]phenyl)-3- methoxyacrylate, methyl (E)-2-(2-(4-phenoxypyridin-2-yloxy)phenyl)-3-methoxyacrylate , methyl (E)-2-[2-(3-n-propyloxy-phenoxy)phenyl]3-methoxyacrylate, methyl (E)-2-[2-(3- isopropyloxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(2- fluorophenoxy)phenoxy]phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(3- ethoxyphenoxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-(4-ie f-butyl-pyridin-2- yloxy)phenyl]-3-methoxyacrylate, methyl (E)-2-[2-[3-(3-cyanophenoxy)phenoxy]phenyl]-3- methoxyacrylate, methyl (E)-2-[2-[(3-methyl-pyridin-2-yloxymethyl)phenyl]-3- methoxyacrylate, methyl (E)-2-[2-[6-(2-methyl-phenoxy)pyrimidin-4-yloxy]phenyl]-3- methoxyacrylate, methyl (E)-2-[2-(5-bromo-pyridin-2-yloxymethyl)phenyl]-3-methoxyacr ylate, methyl (E)-2-[2-(3-(3-iodopyridin-2-yloxy)phenoxy)phenyl]-3-methoxy acrylate, methyl (E)-2- [2-[6-(2-chloropyridin-3-yloxy)pyrimidin-4-yloxy]phenyl]-3-m ethoxyacrylate, methyl (E),(E)-2- [2-(5,6-dimethylpyrazin-2-ylmethyloximinomethyl)phenyl]-3-me thoxyacrylate, methyl (E)-2-{2- [6-(6-methylpyridin-2-yloxy)pyrimidin-4-yloxy]phenyl}-3-meth oxy-acrylate, methyl (E),(E)-2-{ 2-(3-methoxyphenyl)methyloximinomethyl]-phenyl}-3-methoxyacr ylate, methyl (E)-2-{2-(6-(2- azidophenoxy)-pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate, methyl (E),(E)-2-{2-[6- phenylpyrimidin-4-yl)-methyloximinomethyl]phenyl}-3-methoxya crylate, methyl (E),(E)-2-{2- [(4-chlorophenyl)-methyloximinomethyl]-phenyl}-3-methoxyacry late, methyl (E)-2-{2-[6-(2-n- propylphenoxy)-1 ,3,5-triazin-4-yloxy]phenyl}-3-methoxyacrylate, methyl (E),(E)-2-{2-[(3- nitrophenyl)methyloximinomethyl]phenyl}-3-methoxyacrylate, 3-chloro-7-(2-aza-2,7,7- trimethyl-oct-3-en-5-ine), 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, 3-iodo-2- propinyl alcohol, 4-chlorophenyl-3-iodopropargyl formal, 3-bromo-2,3-diiodo-2-propenyl ethylcarbamate, 2,3,3-triiodoallyl alcohol, 3-bromo-2,3-diiodo-2-propenyl alcohol, 3-iodo-2- propinyl n-butylcarbamate, 3-iodo-2-propinyl n-hexylcarbamate, 3-iodo-2-propinyl cyclohexyl- carbamate, 3-iodo-2-propinyl phenylcarbamate; phenol derivatives, such as tribromophenol, tetrachlorophenol, 3-methyl-4-chlorophenol, 3,5-dimethyl-4-chlorophenol, phenoxyethanol, dichlorophene, o-phenylphenol, m-phenylphenol, p-phenylphenol, 2-benzyl-4-chlorophenol, 5-hydroxy-2(5H)-furanone; 4,5-dichlorodithiazolinone, 4,5-benzodithiazolinone, 4,5- trimethylenedithiazolinone, 4,5-dichloro-(3H)-1 ,2-dithiol-3-one, 3,5-dimethyl-tetrahydro-1 ,3,5- thiadiazine-2-thione, N-(2-p-chlorobenzoylethyl)-hexaminium chloride, acibenzolar, acypetacs, alanycarb, albendazole, aldimorph, allicin, allyl alcohol, ametoctradin,

amisulbrom, amobam, ampropylfos, anilazine, asomate, aureofungin, azaconazole, azafendin, azithiram, azoxystrobin, barium polysulfide, benalaxyl, benalaxyl-M, benodanil, benomyl, benquinox, bentaluron, benthiavalicarb, benthiazole, benzalkonium chloride, benzamacril, benzamorf, benzohydroxamic acid, benzovindiflupyr, berberine, bethoxazin, biloxazol, binapacryl, biphenyl, bitertanol, bithionol, bixafen, blasticidin-S, boscalid, bromothalonil, bromuconazole, bupirimate, buthiobate, butylamine calcium polysulfide, captafol, captan, carbamorph, carbendazim, carbendazim chlorhydrate, carboxin,

carpropamid, carvone, CGA41396, CGA41397, chinomethionate, chitosan, chlobenthiazone, chloraniformethan, chloranil, chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlorozolinate, chlozolinate, climbazole, clotrimazole, clozylacon, copper containing compounds such as copper acetate, copper carbonate, copper hydroxide, copper

naphthenate, copper oleate, copper oxychloride, copper oxyquinolate, copper silicate, copper sulphate, copper tallate, copper zinc chromate and Bordeaux mixture, cresol, cufraneb, cuprobam, cuprous oxide, cyazofamid, cyclafuramid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazomet, debacarb, decafentin, dehydroacetic acid, di-2-pyridyl disulphide 1 ,1 '-dioxide, dichlofluanid, diclomezine, dichlone, dicloran, dichlorophen, dichlozoline, diclobutrazol, diclocymet, diethofencarb, difenoconazole, difenzoquat, diflumetorim, O-di-iso-propyl-S-benzyl thiophosphate, dimefluazole,

dimetachlone, dimetconazole, dimethomorph, dimethirimol, diniconazole, diniconazole-M, dinobuton, dinocap, dinocton, dinopenton, dinosulfon, dinoterbon, diphenylamine,

dipyrithione, disulfiram, ditalimfos, dithianon, dithioether, dodecyl dimethyl ammonium chloride, dodemorph, dodicin, dodine, doguadine, drazoxolon, edifenphos, enestroburin, epoxiconazole, etaconazole, etem, ethaboxam, ethirimol, ethoxyquin, ethilicin, ethyl (Z)-N- benzyl-N ([methyl (methyl-thioethylideneamino- oxycarbonyl) amino] thio)^-alaninate, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenitropan, fenoxanil, fenpiclonil, fenpicoxamid, fenpropidin, fenpropimorph, fenpyrazamine, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, flupicolide, fluopyram, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutanil, flutolanil, flutriafol, fluxapyroxad, folpet, formaldehyde, fosetyl, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furfural, furmecyclox, furophanate, glyodin, griseofulvin, guazatine, halacrinate, hexachlorobenzene, hexachlorobutadiene, hexachlorophene, hexaconazole, hexylthiofos, hydrargaphen, hydroxyisoxazole, hymexazole, imazalil, imazalil sulphate, imibenconazole, iminoctadine, iminoctadine triacetate, inezin, iodocarb, ipconazole, ipfentrifluconazole, iprobenfos, iprodione, iprovalicarb, isopropanylbutyl carbamate, isoprothiolane, isopyrazam, isotianil, isovaledione, izopamfos, kasugamycin, kresoxim-methyl, LY186054, LY21 1795, LY248908, mancozeb, mandipropamid, maneb, mebenil, mecarbinzid, mefenoxam, mefentrifluconazole, mepanipyrim, mepronil, mercuric chloride, mercurous chloride, meptyldinocap, metalaxyl, metalaxyl-M, metam, metazoxolon, metconazole, methasulfocarb, methfuroxam, methyl bromide, methyl iodide, methyl isothiocyanate, metiram, metiram-zinc, metominostrobin, metrafenone, metsulfovax, milneb, moroxydine, myclobutanil, myclozolin, nabam, natamycin, neoasozin, nickel dimethyldithiocarbamate, nitrostyrene, nitrothal-iso- propyl, nuarimol, octhilinone, ofurace, organomercury compounds, orysastrobin, osthol, oxadixyl, oxasulfuron, oxathiapiprolin, oxine-copper, oxolinic acid, oxpoconazole,

oxycarboxin, parinol, pefurazoate, penconazole, pencycuron, penflufen, pentachlorophenol, penthiopyrad, phenamacril, phenazin oxide, phosdiphen, phosetyl-AI, phosphorus acids, phthalide, picoxystrobin, piperalin, polycarbamate, polyoxin D, polyoxrim, polyram, probenazole, prochloraz, procymidone, propamidine, propamocarb, propiconazole, propineb, propionic acid, proquinazid, prothiocarb, prothioconazole, pydiflumetofen, pyracarbolid, pyraclostrobin, pyrametrostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyridinitril, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, pyroxychlor, pyroxyfur, pyrrolnitrin, quaternary ammonium compounds, quinacetol, quinazamid, quinconazole, quinomethionate, quinoxyfen, quintozene, rabenzazole, santonin, sedaxane, silthiofam, simeconazole, sipconazole, sodium pentachlorophenate, spiroxamine, streptomycin, sulphur, sultropen, tebuconazole, tebfloquin, tecloftalam, tecnazene, tecoram, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, 2-(thiocyanomethylthio) benzothiazole, thiophanate- methyl, thioquinox, thiram, tiadinil, timibenconazole, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triamiphos, triarimol, triazbutil, triazoxide, tricyclazole, tridemorph, trifloxystrobin, triflumazole, triforine, triflumizole, triticonazole, uniconazole, urbacide, validamycin, valifenalate, vapam, vinclozolin, zarilamid, zineb, ziram, and zoxamide. The compounds of the invention may also be used in combination with anthelmintic agents. Such anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP-444964 and EP-594291 . Additional anthelmintic agents include

semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO-9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.

The compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE- 19520936.

The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO 96/15121 and also with anthelmintic active cyclic depsipeptides such as those described in WO 96/1 1945, WO 93/19053, WO 93/25543, EP 0 626 375, EP 0 382 173, WO 94/19334, EP 0 382 173, and EP 0 503 538.

The compounds of the invention may be used in combination with other

ectoparasiticides; for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like;

neonicotinoids such as imidacloprid and the like.

The compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers WO 95/19363 or WO 04/72086, particularly the compounds disclosed therein.

Other examples of such biologically active compounds that the compounds of the invention may be used in combination with include but are not restricted to the following:

Organophosphates: acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, methacriphos, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phosfolan, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos-methyl, profenofos, propaphos, proetamphos, prothiofos, pyraclofos,

pyridapenthion, quinalphos, sulprophos, temephos, terbufos, tebupirimfos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion.

Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801 , isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m- cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.

Pyrethroids: acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E)-(1 R)-cis-2,2- dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxy late, bifenthrin, beta- cyfluthrin, cyfluthrin, a-cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin((S)- cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, lambda-cyhalothrin, permethrin, phenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, theta-cypermethrin, silafluofen, t-fluvalinate, tefluthrin, tralomethrin, Zeta-cypermethrin.

Arthropod growth regulators: a) chitin synthesis inhibitors: benzoylureas:

chlorfluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron, buprofezin, diofenolan, hexythiazox, etoxazole, chlorfentazine; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide; c) juvenoids: pyriproxyfen, methoprene (including S-methoprene), fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen.

Other antiparasitics: acequinocyl, amitraz, AKD-1022, ANS-1 18, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG- 505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin,

dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, ethofenprox, fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, IKI-220, kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651 , WL-108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1 1 1 1 , R-195,RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601 , silafluofen, silomadine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301 .

Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.

Bactericides: chlortetracycline, oxytetracycline, streptomycin.

Other biological agents: enrofloxacin, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, omeprazole, tiamulin, benazepril, pyriprole, cefquinome, florfenicol, buserelin, cefovecin, tulathromycin, ceftiour, carprofen,

metaflumizone, praziquarantel, triclabendazole. The following mixtures of the compounds of Formula (I) with active ingredients are preferred. The abbreviation "TX" means one compound selected from the group consisting of the compounds as represented in Tables A1 to A8 (above) or Table E or F (below): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,

an acaricide selected from the group of substances consisting of 1 ,1 -bis(4-chloro- phenyl)-2-ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-/V-methyl-/V-1 -naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha-cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate (71 ) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate (alternative name) + TX, broflanilide [1207727-04-5] + TX, bromocyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50'439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos (131 ) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name) [CCN] + TX, coumaphos (174) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201 ) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX,

dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071 ) + TX, dimefox (1081 ) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex- diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, ethion (309) + TX, ethoate-methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161 ) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137

(development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl

cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441 ) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261 ) + TX, mesulfen (alternative name) [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC- 184 (compound code) + TX, NC-512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX,

oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, phenkapton (1330) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX,

polychloroterpenes (traditional name) (1347) + TX, polynactins (alternative name) (653) + 5 TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671 ) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1 ) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-

10 17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI- 121 (development code) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX,

15 tau-fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX, tetrachlorvinphos (777) + TX, tetradifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thiafenox (alternative name) + TX, thiocarboxime (1431 ) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) +

20 TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX,

trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,

an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne

25 [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hydrated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,

an anthelmintic selected from the group of substances consisting of abamectin (1 ) +

30 TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,

35 an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1 -hydroxy-1 /-/- pyridine-2-thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX, fenaminosulf (1 144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX,

a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51 ) + TX, Bacillus thuringiensis subsp.

israelensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51 ) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea (alternative name) (151 ) + TX, Cryptolaemus montrouzieri (alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191 ) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name) (300) + TX, Helicoverpa zea NPV (alternative name) (431 ) + TX, Heterorhabditis bacteriophora and H. megidis

(alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491 ) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var. acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp. (alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX, Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinernema bibionis (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema feltiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) + TX, Steinernema riobrave (alternative name) (742) + TX, Steinernema riobravis (alternative name) (742) + TX,

Steinernema scapterisci (alternative name) (742) + TX, Steinernema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX, bacillus subtilis var. amyloliquefaciens Strain FZB24 (available from Novozymes Biologicals Inc., 5400 Corporate Circle, Salem, VA 24153, U.S.A. and known under the trade name Taegro®) + TX,

a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,

a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron (alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine

(alternative name) [CCN] and uredepa (alternative name) [CCN] + TX,

an insect pheromone selected from the group of substances consisting of (£)-dec-5- en-1 -yl acetate with (£)-dec-5-en-1 -ol (lUPAC name) (222) + TX, (£)-tridec-4-en-1 -yl acetate (lUPAC name) (829) + TX, (£)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (£,Z)- tetradeca-4,10-dien-1 -yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1 -yl acetate (lUPAC name) (285) + TX, (Z)-hexadec-l 1 -enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1 - en-1 -yl acetate (lUPAC name) (437) + TX, (Z)-hexadec-13-en-1 1 -yn-1 -yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1 -al (lUPAC name) (782) + TX, (Z)-tetradec-9-en-1 -ol (lUPAC name) (783) + TX, (Z)-tetradec-9- en-1 -yl acetate (lUPAC name) (784) + TX, (7£,9Z)-dodeca-7,9-dien-1 -yl acetate (lUPAC name) (283) + TX, (9Z,1 1 £)-tetradeca-9,1 1 -dien-1-yl acetate (lUPAC name) (780) + TX, (9Z, 12£)-tetradeca-9,12-dien-1 -yl acetate (lUPAC name) (781 ) + TX, 14-methyloctadec-1 - ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1 -yl acetate (lUPAC name) (286) + TX, dodec-9-en-1 -yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1 -yl acetate (lUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421 ) + TX, grandlure I (alternative name) (421 ) + TX, grandlure II (alternative name) (421 ) + TX, grandlure III (alternative name) (421 ) + TX, grandlure IV (alternative name) (421 ) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481 ) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2,13-dien-1 - yl acetate (lUPAC name) (588) + TX, octadeca-3,13-dien-1 -yl acetate (lUPAC name) (589) + TX, orfralure (alternative name) [CCN] + TX, oryctalure (alternative name) (317) + TX, ostramone (alternative name) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetradec-1 1 -en-1 -yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure Bi (alternative name) (839) + TX, trimedlure B2 (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX,

an insect repellent selected from the group of substances consisting of 2-(octylthio)- ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethylamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,

an insecticide selected from the group of substances consisting of 1 -dichloro-1 - nitroethane (lUPAC/Chemical Abstracts name) (1058) + TX, 1 ,1 -dichloro-2,2-bis(4- ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1 -bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2- trichloro-1 -(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451 ) + TX, 2,2-dichlorovinyl 2- ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2-(4,5-dimethyl-1 ,3-dioxolan-2- yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5- xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1 -chloroprop-1 - ene (lUPAC name) (917) + TX, 3-methyl-1 -phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl-3-oxocyclohex-1 -enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1 ) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion (alternative name) [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861 ) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin (alternative name) [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha-ecdysone (alternative name) [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (alternative name) (41 ) + TX, azamethiphos (42) + TX, azinphos- ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta-cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S- cyclopentenyl isomer (alternative name) (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (alternative name) (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131 ) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141 ) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocythrin (alternative name) + TX, cloethocarb (999) + TX, closantel (alternative name)

[CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate

[CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1 ) + TX, cryolite (alternative name) (177) + TX, CS 708 (development code) (1012) + TX,

cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX, cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate (alternative name) [CCN] + TX, d-limonene (alternative name) [CCN] + TX, cZ-tetramethrin (alternative name) (788) + TX, DAEP (1031 ) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofuran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX,

demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-O (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051 ) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081 ) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX, dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin (alternative name) [CCN] + TX, DSP (1 1 15) + TX, ecdysterone (alternative name) [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin (alternative name) [CCN] + TX, esfenvalerate (302) + TX, etaphos (alternative name) [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-methyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD

(alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451 -65- 7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (121 1 ) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX, iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231 ) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxy- aminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) [CCN] + TX, juvenile hormone III (alternative name) [CCN] + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251 ) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261 ) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531 ) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX,

metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naftalofos (alternative name) [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (131 1 ) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI- 0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4-methyl-2-oxo-2H-chromen-7-yl

phosphorothioate (lUPAC name) (1074) + TX, Ο,Ο-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, O, Ο,Ο', O'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron (alternative name) [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor (1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651 ) + TX, pirimiphos- ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, polychloroterpenes (traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (alternative name) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternative name) [CCN] + TX, quinalphos (71 1 ) + TX, quinalphos- methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabadilla (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (lUPAC/Chemical Abstracts name) (1399) + TX, sodium hexafluorosilicate (1400) + TX, sodium

pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401 ) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta- cypermethrin (204) + TX, thiacloprid (791 ) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431 ) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate (798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441 ) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (alternative name) (725) + TX, veratrine (alternative name) (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternative name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121 -52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon [337458-27-2] + TX, spinetoram [187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1 ] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO 2012/0921 15) + TX, a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX,

pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71 -3] + TX,

a nematicide selected from the group of substances consisting of AKD-3088

(compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2-dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1 ,1 -dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine (lUPAC name) (980) + TX, 5-methyl-6- thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid (lUPAC name) (1286) + TX, 6- isopentenylaminopurine (alternative name) (210) + TX, abamectin (1 ) + TX, acetoprole

[CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541 (compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben

(alternative name) + TX, cadusa thiazolidines fos (109) + TX, carbofuran (1 18) + TX, carbon disulfide (945) + TX, carbosulfan (1 19) + TX, chloropicrin (141 ) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051 ) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin

(alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231 ) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition

(alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX, phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,

a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,

a plant activator selected from the group of substances consisting of acibenzolar (6) +

TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,

a rodenticide selected from the group of substances consisting of 2-isovalerylindan- 1 ,3-dione (lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha-chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX, bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341 ) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371 ) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851 ) and zinc phosphide (640) + TX,

a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)- ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2- enone (lUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB- 599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX, an animal repellent selected from the group of substances consisting of

anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4- amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX, a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,

a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX,

5 and biologically active compounds selected from the group consisting of ametoctradin

[865318-97-4] + TX, amisulbrom [348635-87-0] + TX, azaconazole [60207-31 -0] + TX, benzovindiflupyr [1072957-71 -1] + TX, bitertanol [70585-36-3] + TX, bixafen [581809-46-3] + TX, bromuconazole [1 16255-48-2] + TX, coumoxystrobin [850881 -70-8] + TX,

cyproconazole [94361 -06-5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-

10 24-3] + TX, enoxastrobin [238410-1 1 -2] + TX, epoxiconazole [106325-08-0] + TX,

fenbuconazole [1 14369-43-6] + TX, fenpyrazamine [473798-59-3] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21 -0] + TX, fluxapyroxad [907204-31 -3] + TX, fluopyram [658066-35-4] + TX, fenaminstrobin [366815-39-6] + TX, isofetamid [875915-78-9] + TX, hexaconazole [79983-71 -4] + TX, imazalil [35554-44-0] + TX,

15 imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, ipfentrifluconazole

[1417782-08-1] + TX, isotianil [224049-04-1 ] + TX, mandestrobin [173662-97-0] (can be prepared according to the procedures described in WO 2010/093059) + TX,

mefentrifluconazole [1417782-03-6] + TX, metconazole [1251 16-23-6] + TX, myclobutanil [88671 -89-0] + TX, paclobutrazol [76738-62-0] + TX, pefurazoate [101903-30-4] + TX,

20 penflufen [494793-67-8] + TX, penconazole [66246-88-6] + TX, prothioconazole [178928-70- 6] + TX, pyrifenox [88283-41 -4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207- 90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [1 12281 -77-3] + TX, triadimefon [43121 -43-3] + TX, triadimenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771 -68-5]

25 + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71 -9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221 -53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidin [67306-00-7] + TX, fenpropimorph [67564-91 -4] + TX, spiroxamine [1 18134- 30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61 -2] + TX, mepanipyrim

[1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX,

30 fludioxonil [131341 -86-1] + TX, fluindapyr [1383809-87-7] + TX, benalaxyl [71626-1 1 -4] + TX, furalaxyl [57646-30-7] + TX, metalaxyl [57837-19-1 ] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21 -7] + TX, debacarb [62732-91 -6] + TX, fuberidazole [3878-19-1 ] + TX, thiabendazole [148-79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201 -58-

35 9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61 -8] + TX, procymidone [32809- 16-8] + TX, vinclozoline [50471 -44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68- 4] + TX, fenfuram [24691 -80-3] + TX, flutolanil [66332-96-5] + TX, flutianil [958647-10-4] + TX, mepronil [55814-41 -0] + TX, oxycarboxin [5259-88-1 ] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65-2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961 -52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 5 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1 ] + TX, trifloxystrobin [141517-21 -7] + TX, orysastrobin

[248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, pyraoxystrobin [862588-1 1 -2] + TX, ferbam [14484-64-1 ] + TX, mancozeb [8018-01 -7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071 -83-9] + TX, thiram

10 [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425-06-1 ] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205-21 -4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731 -27-1 ] + TX, bordeaux mixture [801 1 -63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758- 98-7] + TX, copperoxid [1317-39-1] + TX, mancopper [53988-93-5] + TX, oxine-copper

15 [10380-28-6] + TX, dinocap [131 -72-6] + TX, nitrothal-isopropyl [10552-74-6] + TX,

edifenphos [17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl

[57018-04-9] + TX, acibenzolar-S-methyl [135158-54-2] + TX, anilazine [101 -05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-

20 01 -2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid

[180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [1 17-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20-9] + TX, dimethomorph [1 10488-70-5] + TX, SYP-LI90 (Flumorph) [21 1867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] +

25 TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [1 15852-48- 7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1 ] + TX, iprovalicarb

[140923-17-7] + TX, IKF-916 (Cyazofamid) [1201 16-88-3] + TX, kasugamycin [6980-18-3] +

30 TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron

[66063-05-6] + TX, phthalide [27355-22-2] + TX, picarbutrazox [500207-04-5] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41 -1 ] + TX, proquinazid [189278-12-4] + TX, pydiflumetofen [1228284-64-7] + TX, pyrametostrobin [915410-70-7] + TX, pyroquilon [57369-32-1] + TX, pyriofenone [688046-61 -9] + TX,

35 pyribencarb [799247-52-2] + TX, pyrisoxazole [847749-37-5] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, Timorex Gold™ (plant extract containing tea tree oil from the Stockton Group) + TX, tebufloquin [376645-78-2] + TX, tiadinil [223580-51 -6] + TX, triazoxide [72459-58-6] + TX, tolprocarb [91 1499-62-2] + TX, triclopyricarb [902760-40-1 ] + TX, tricyclazole [41814-78-2] + TX, triforine [26644-46-2] + TX, validamycin [37248-47-8] + TX, valifenalate [283159-90-0] + TX, zoxamide (RH7281 )

[156052-68-5] + TX, mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1 ] + TX, phenamacril + TX, sedaxane [874967-67-6] + TX, trinexapac-ethyl [95266-40-3] + TX, 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4- tetrahydro-1 ,4-methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3- difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX, [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3- [(cyclopropylcarbonyl)oxy]- 1 ,3,4,4a,5,6,6a,12,12a,12b-decahydro-6,12-dihydroxy-4,6a,12b- trimethyl-1 1 -oxo-9-(3-pyridinyl)-2/-/, 1 1 /-/naphtho[2, 1 -b]pyrano[3,4-e]pyran-4-yl]methyl- cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1 -oxopropyl)- N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1 -methoxy-1 -(trifluoromethyl)ethyl]phenyl]-1 H- pyrazole-4-carboxamide [926914-55-8] + TX,

or a biologically active compound selected from the group consisting of N-[(5-chloro-

2-isopropyl-phenyl)methyl]-N-cyclopropyl-3-(difluoromethy l)-5-fluoro-1 -methyl-pyrazole-4- carboxamide (can be prepared according to the procedures described in WO 2010/130767) + TX, 2,6-Dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetrone (can be prepared according to the procedures described in WO 201 1/138281 ) + TX, 6-ethyl-5,7- dioxo-pyrrolo[4,5][1 ,4]dithiino[1 ,2-c]isothiazole-3-carbonitrile + TX, 4-(2-bromo-4-fluoro- phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3- amine (can be prepared according to the procedures described in WO 2012/031061 ) + TX, 3-(difluoromethyl)-N-(7- fluoro-1 ,1 ,3-trimethyl-indan-4-yl)-1 -methyl-pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2012/084812) + TX, CAS 850881 -30-0 + TX, 3-(3,4-dichloro-1 ,2-thiazol-5-ylmethoxy)-1 ,2-benzothiazole 1 ,1 -dioxide (can be prepared according to the procedures described in WO 2007/129454) + TX, 2-[2-[(2,5- dimethylphenoxy)methyl]phenyl]-2-methoxy-N-methyl-acetamide + TX, 3-(4,4-difluoro-3,4- dihydro-3,3-dimethylisoquinolin-1 -yl)quinolone (can be prepared according to the procedures described in WO 2005/070917) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3- quinolyl)oxy]phenyl]propan-2-ol (can be prepared according to the procedures described in WO 201 1/081 174) + TX, 2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl ]propan- 2-ol (can be prepared according to the procedures described in WO 201 1/081 174) + TX, oxathiapiprolin + TX [1003318-67-9], tert-butyl N-[6-[[[(1 -methyltetrazol-5-yl)-phenyl- methylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, N-[2-(3,4-difluorophenyl)phenyl]-3- (trifluoromethyl)pyrazine-2-carboxamide (can be prepared according to the procedures described in WO 2007/ 072999) + TX, 3-(difluoromethyl)-1 -methyl-N-[(3R)-1 ,1 ,3- trimethylindan-4-yl]pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2014/013842) + TX, 2,2,2-trifluoroethyl N-[2-methyl-1 -[[(4- methylbenzoyl)amino]methyl]propyl]carbamate + TX, (2RS)-2-[4-(4-chlorophenoxy)-a,a,o trifluoro-o-tolyl]-1 -(1 H-1 ,2,4-triazol-1 -yl)propan-2-ol + TX, (2RS)-2-[4-(4-chlorophenoxy)- a,a,a-trifluoro-o-tolyl]-3-methyl-1 -(1 H-1 ,2,4-triazol-1 -yl)butan-2-ol + TX, 2-(difluoromethyl)-N- 5 [(3R)-3-ethyl-1 ,1 -dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[3- ethyl-1 ,1 -dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, N'-(2,5-dimethyl-4-phenoxy- phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl- phenyl]-N-ethyl-N-methyl-formamidine (can be prepared according to the procedures described in WO 2007/031513) + TX, [2-[3-[2-[1 -[2-[3,5-bis(difluoromethyl)pyrazol-1 -

10 yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-y l]-3-chloro-phenyl] methanesulfonate (can be prepared according to the procedures described in WO 2012/025557) + TX, but-3- ynyl N-[6-[[(Z)-[(1 -methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2- pyridyl]carbamate (can be prepared according to the procedures described in WO

2010/000841 ) + TX, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]met hyl]-4H-1 ,2,4-

15 triazole-3-thione (can be prepared according to the procedures described in WO

2010/146031 ) + TX, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl- phenyl]methyl]carbamate + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6- trifluorophenyl)pyridazine (can be prepared according to the procedures described in WO 2005/121 104) + TX, 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol

20 (can be prepared according to the procedures described in WO 2013/024082) + TX, 3- chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine (can be prepared according to the procedures described in WO 2012/020774) + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl- pyridazine-3-carbonitrile (can be prepared according to the procedures described in

WO 2012/020774) + TX, (R)-3-(difluoromethyl)-1 -methyl-N-[1 ,1 ,3-trimethylindan-4-

25 yl]pyrazole-4-carboxamide (can be prepared according to the procedures described in

WO 201 1/162397 ) + TX, 3-(difluoromethyl)-N-(7-fluoro-1 ,1 ,3-trimethyl-indan-4-yl)-1 -methyl- pyrazole-4-carboxamide (can be prepared according to the procedures described in WO 2012/084812) + TX, 1 -[2-[[1 -(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4- methyl-tetrazol-5-one (can be prepared according to the procedures described in WO

30 2013/162072) + TX, 1 -methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1 - yl)phenoxy]methyl]phenyl]tetrazol-5-one (can be prepared according to the procedures described in WO 2014/051 165) + TX, (Z,2E)-5-[1 -(4-chlorophenyl)pyrazol-3-yl]oxy-2- methoxyimino-N,3-dimethyl-pent-3-enamide + TX, (4-phenoxyphenyl)methyl 2-amino-6- methyl-pyridine-3-carboxylate + TX, N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-

35 (difluoromethyl)-5-fluoro-1 -methylpyrazole-4-carboxamide [1255734-28-1 ] (can be prepared according to the procedures described in WO 2010/130767) + TX, 3-(difluoromethyl)-N-[(R)- 2,3-dihydro-1 ,1 ,3-trimethyl-1 H-inden-4-yl]-1 -methylpyrazole-4-carboxamide [1352994-67-2] + TX, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamid ine + TX, N'-[4-(4,5- dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-met hyl-formamidin + TX, N'-(2,5- dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine + TX, N'-[4-(4,5-dichloro-thiazol- 2-yloxy -2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine + TX,

(fenpicoxamid [517875-34-2] (as described in

WO 2003/035617)) + TX, (1 S)-2,2-bis(4-fluorophenyl)-1 -methylethyl N-{[3-(acetyloxy)-4- methoxy-2-pyridyl]carbonyl}-L-alaninate [1961312-55-9] (as described in WO 2016/122802) + TX, 2-(difluoromethyl)-N-(1 ,1 ,3-trimethylindan-4-yl)pyridine-3-carboxamide + TX, 2- (difluoromethyl)-N-(3-ethyl-1 ,1 -dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2- (difluoromethyl)-N-(l ,1 -dimethyl-3-propyl-indan-4-yl)pyridine-3-carboxamide + TX, 2- (difluoromethyl)-N-(3-isobutyl-1 ,1 -dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2- (difluoromethyl)-N-[(3R)-1 ,1 ,3-trimethylindan-4-yl]pyridine-3-carboxamide + TX, 2- (difluoromethyl)-N-[(3R)-3-ethyl-1 ,1 -dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, and 2- (difluoromethyl)-N-[(3R)-1 ,1 -dimethyl-3-propyl-indan-4-yl]pyridine-3-carboxamide + TX, wherein each of these carboxamide compounds can be prepared according to the procedures described in WO 2014/095675 and/or WO 2016/139189.

The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known.

Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop

Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1 ). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.

Most of the active ingredients described above are referred to hereinabove by a so- called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. "CAS Reg. No" means the Chemical Abstracts Registry Number.

The active ingredient mixture of the compounds of formula (I) selected from one compound as represented in Tables A1 to A8 (above) or Table E or F (below) is preferably in a mixing ratio of from 100:1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20:1 to 1 :20, even more especially from 10:1 to 1 :10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2:1 to 1 :2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1 :1 , or 5:1 , or 5:2, or 5:3, or 5:4, or 4:1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2:1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750.

Those mixing ratios are by weight.

The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.

The mixtures comprising a compound as represented in Tables A1 to A8 (above) or

Table E or F (below), and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying a compound as represented in Tables A1 to A8 (above) or Table E or F (below) and the active ingredient(s) as described above, is not essential for working the present invention.

The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.

The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds (I) for the preparation of these compositions are also a subject of the invention.

Another aspect of the invention is related to the use of a compound of Formula (I) or of a preferred individual compound as defined herein, of a composition comprising at least one compound of Formula (I) or at least one preferred individual compound as above- defined, or of a fungicidal or insecticidal mixture comprising at least one compound of Formula (I) or at least one preferred individual compound as above-defined, in admixture with other fungicides or insecticides as described above, for controlling or preventing infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living materials by insects or by phytopathogenic microorganisms, preferably fungal organisms.

A further aspect of invention is related to a method of controlling or preventing an infestation of plants, e.g. useful plants such as crop plants, propagation material thereof, e.g. seeds, harvested crops, e.g. harvested food crops, or of non-living materials by

phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, which comprises the application of a compound of formula (I) or of a preferred individual compound as above-defined as active ingredient to the plants, to parts of the plants or to the locus thereof, to the propagation material thereof, or to any part of the non-living materials.

Controlling or preventing means reducing infestation by insects or by phytopathogenic or spoilage microorganisms or organisms potentially harmful to man, especially fungal organisms, to such a level that an improvement is demonstrated.

A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects which comprises the application of a compound of formula (I), or an agrochemical composition which contains at least one of said compounds, is foliar application. The frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of formula (I) can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field. The compounds of formula (I) may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.

A formulation, e.g. a composition containing the compound of formula (I), and, if desired, a solid or liquid adjuvant or monomers for encapsulating the compound of formula (I), may be prepared in a known manner, typically by intimately mixing and/or grinding the compound with extenders, for example solvents, solid carriers and, optionally, surface active compounds (surfactants).

The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is preferably 1 g to 2000 g of active ingredient per hectare, more preferably 10 to 1000 g/ha, most preferably 10 to 600 g/ha. When used as seed drenching agent, convenient dosages are from 10mg to 1 g of active substance per kg of seeds.

When the combinations of the present invention are used for treating seed, rates of 0.001 to 50 g of a compound of formula (I) per kg of seed, preferably from 0.01 to 10g per kg of seed are generally sufficient.

Suitably, a composition comprising a compound of formula (I) according to the present invention is applied either preventative, meaning prior to disease development or curative, meaning after disease development.

The compositions of the invention may be employed in any conventional form, for example in the form of a twin pack, a powder for dry seed treatment (DS), an emulsion for seed treatment (ES), a flowable concentrate for seed treatment (FS), a solution for seed treatment (LS), a water dispersible powder for seed treatment (WS), a capsule suspension for seed treatment (CF), a gel for seed treatment (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.

Such compositions may be produced in conventional manner, e.g. by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulating ingredients such as surfactants, biocides, anti-freeze, stickers, thickeners and compounds that provide adjuvancy effects). Also conventional slow release formulations may be employed where long lasting efficacy is intended. Particularly formulations to be applied in spraying forms, such as water dispersible concentrates (e.g. EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvancy effects, e.g. the ondensation product of formaldehyde with naphthalene sulphonate, an alkylarylsulphonate, a lignin sulphonate, a fatty alkyl sulphate, and ethoxylated alkylphenol and an ethoxylated fatty alcohol.

A seed dressing formulation is applied in a manner known per se to the seeds employing the combination of the invention and a diluent in suitable seed dressing formulation form, e.g. as an aqueous suspension or in a dry powder form having good adherence to the seeds. Such seed dressing formulations are known in the art. Seed dressing formulations may contain the single active ingredients or the combination of active ingredients in encapsulated form, e.g. as slow release capsules or microcapsules.

In general, the formulations include from 0.01 to 90% by weight of active agent, from 0 to 20% agriculturally acceptable surfactant and 10 to 99.99% solid or liquid formulation inerts and adjuvant(s), the active agent consisting of at least the compound of formula (I) together with component (B) and (C), and optionally other active agents, particularly microbiocides or conservatives or the like. Concentrated forms of compositions generally contain in between about 2 and 80%, preferably between about 5 and 70% by weight of active agent. Application forms of formulation may for example contain from 0.01 to 20% by weight, preferably from 0.01 to 5% by weight of active agent. Whereas commercial products will preferably be formulated as concentrates, the end user will normally employ diluted formulations.

Whereas it is preferred to formulate commercial products as concentrates, the end user will normally use dilute formulations.

EXAMPLES

The Examples which follow serve to illustrate the invention. Certain compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1 .5 ppm, 0.8 ppm or 0.2 ppm.

Throughout this description, temperatures are given in degrees Celsius and "m.p." means melting point. LC/MS means Liquid Chromatography Mass Spectroscopy and the description of the apparatus and the methods are:

Method G:

Spectra were recorded on a Mass Spectrometer (ACQUITY UPLC) from Waters (SQD, SQDII or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V,

Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.

Column: Waters UPLC HSS T3 , 1 .8 μπι, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH, gradient: 10-100% B in 1 .2 min; Flow (ml/min) 0.85 Method H:

Spectra were recorded on a Mass Spectrometer (ACQUITY UPLC) from Waters (SQD, SQDII or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V,

Extractor: 2.00 V, Source Temperature: 150°C, Desolvation Temperature: 350°C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.

Column: Waters UPLC HSS T3, 1 .8 μπι, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH, gradient: 10-100% B in 2.7 min; Flow (ml/min) 0.85

Method I:

Spectra were recorded on a Mass Spectrometer (ACQUITY UPLC) from Waters (SQD, SQDII or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary (kV) 3.5, Cone (V) 30.00, Extractor (V) 3.00, Source Temperature (°C) 150, Desolvation Temperature (°C) 400, Cone Gas Flow (L/Hr) 60, Desolvation Gas Flow (L/Hr) 700, Mass range: 140 to 800 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector.

Solvent degasser, binary pump, heated column compartment and diode-array detector.

Column: Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1.8 micron; Temperature: 60°C, DAD Wavelength range (nm): 210 to 400. Solvent Gradient A: Water/Methanol 9:1 ,0.1 % formic acid and Solvent B:

Acetonitrile,0.1 % formic acid

Time (minutes) A (%) B (%) Flow rate (ml/min)

0 100 0 0.75

2.5 0 100 0.75 2.8 0 100 0.75

3.0 100 0 0.75

Formulation Examples

Wettable powders a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % sodium lignosulfonate 5 % 5 %

sodium lauryl sulfate 3 % - 5 % sodium diisobutylnaphthalenesulfonate - 6 % 10 % phenol polyethylene glycol ether - 2 %

(7-8 mol of ethylene oxide)

highly dispersed silicic acid 5 % 10 % 10 %

Kaolin 62 % 27 %

The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.

Powders for drv seed treatment a) b) c) active ingredient [compound of formula (I)] 25 % 50 % 75 % light mineral oil 5 % 5 % 5 % highly dispersed silicic acid 5 % 5 % -

Kaolin 65 % 40 % -

Talcum - 20 The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.

Emulsifiable concentrate

active ingredient [compound of formula (I)] 10 %

octylphenol polyethylene glycol ether 3 %

(4-5 mol of ethylene oxide)

calcium dodecylbenzenesulfonate 3 %

castor oil polyglycol ether (35 mol of ethylene oxide) 4 %

Cyclohexanone 30 %

xylene mixture 50 %

Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water. Dusts a) b) c)

Active ingredient [compound of formula (I)] 5 % 6 % 4 % talcum 95 %

Kaolin - 94 %

mineral filler - - 96 %

Ready-for-use dusts are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.

Extruder granules

Active ingredient [compound of formula (I)] 15 %

sodium lignosulfonate 2 %

carboxymethylcellulose 1 %

Kaolin 82 %

The active ingredient is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

Coated granules

Active ingredient [compound of formula (I)]

polyethylene glycol (mol. wt. 200)

Kaolin The finely ground active ingredient is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.

Suspension concentrate

active ingredient [compound of formula (I)] 40 %

propylene glycol 10 %

nonylphenol polyethylene glycol ether (15 mol of ethylene oxide) 6 %

Sodium lignosulfonate 10 %

carboxymethylcellulose 1 %

silicone oil (in the form of a 75 % emulsion in water) 1 %

Water 32 % The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion. Flowable concentrate for seed treatment

active ingredient [compound of formula (I)] 40 % propylene glycol 5 % copolymer butanol PO/EO 2 % tristyrenephenole with 10-20 moles EO 2 %

1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 % monoazo-pigment calcium salt 5 %

Silicone oil (in the form of a 75 % emulsion in water) 0.2 %

Water 45.3 %

The finely ground active ingredient is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

Slow Release Capsule Suspension

28 parts of a combination of the compound of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate- mixture (8:1 ). This mixture is emulsified in a mixture of 1 .2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51 .6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1 ,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed.

The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns.

The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.

Preparation examples

Example 1 : N-[1 -[(5-chloro-2-thienyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide.

Step 1 : Preparation of ethyl 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanoate. To a solution of ethyl 2,4-dimethylpentanoate (0.36 g, 2.28 mmol) in tetrahydrofuran (0.25 M, 9.1 mL) at -70 °C was added a solution of lithium diisopropylamide (2 M in THF, 1 .3 equiv., 1.5 mL, 2.96 mmol ). The solution was stirred at -70 °C for 1 h. 2-chloro-5- (chloromethyl)thiophene (1 .3 equiv., 0.37 mL, 2.96 mmol) was then added and the orange solution was allowed to warmup to rt and stirred at this temperature for 16 h. The reaction mixture was quenched with saturated aqueous NH4CI solution. The two phases were separated and the aqueous phase was extracted twice with ethyl acetate. The combined organic phase was washed with brine, dried over anhydrous Na2S0 ₄ , filtered and

concentrated. Purification of the residue by flash chromatography gave ethyl 2-[(5-chloro-2- thienyl)methyl]-2,4-dimethyl-pentanoate (0.25 g, 38% yield) as a yellow liquid : LC-MS (Method G), Rt = 1.35 min;

¹ H NMR (400 MHz, CHLOROFORM-d) δ ppm 0.91 (d, 6H) 1.15 (s, 3H) 1.28 (t, 3H) 1 .45 (m, 1 H) 1 .68-1 .75 (m, 21-1) 2.71 (d, 1 H) 3.19 (d, 1 H) 4.14 (q, 2H) 6.52 (d, 1 1-1) 6.70 (d, 1 H).

Step 2: Preparation of 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanoic acid.

To a solution of ethyl 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanoate (0.17 g, 0.58 mmol) in dioxane (0.2 M, 2.9 mL) and water (0.5 M, 1.2mL) was added an aqueous solution of sodium hydroxide (2 M) (5 equiv. , 1 .45 mL, 2.9 mmol) followed by an aqueous solution of tetrabutylammonium hydroxide (40 % w/w) (2 equiv., 0.75 g, 1.16 mmol) dropwise. The brown solution was stirred at 1 10 °C for 26 h. The reaction mixture was then diluted with dichloromethane and the two phases were separated. The aqueous phase was then acidified with an aqueous solution of hydrochloric acid (2 M) and extracted twice with dichloromethane. This organic phase was washed with brine, dried over Na2S0 ₄ , filtered and concentrated to give 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanoic acid (0.1 15 g, 75% yield) as a yellow gum : LC-MS (Method G), Rt = 1 .12 min; MS: (M+1 ) = 259-261 ;

¹ H NMR (400 MHz, MeOD-d) δ ppm 0.95 (dd, 6H) 1 .15 (s, 3H) 1 .45 (m, 1 H) 1 .70 (m, 1 H) 1.80 (m, 1 H) 2.80 (d, 1 H) 3.20 (d, 1 H) 6.68 (d, 1 H) 6.80 (d, 1 H). Step 3: Preparation of 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanamide.

To a solution of 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanoic acid (0.1 1 g, 0.42 mmol) in dichloromethane (0.1 M, 4.2 mL) and 3 drops of dimethylformamide was added oxalyl chloride (0.048 mL, 1 .3 equiv., 0.55 mmol). The solution was stirred at rt for 1 h, then concentrated under vacuum. The residue was dissolved in dichloromethane (0.1 M, 4.2 mL) and triethylamine (0.176 mL, 3 equiv., 1 .27 mmol) was added followed by ammonium chloride (0.045 g, 2 equiv., 0.84 mmol). The reaction mixture was stirred at rt for 1 h, then diluted with dichloromethane and washed with water and with brine, dried over Na2S0 ₄ , filtered and concentrated. Purification by flash chromatography gave 2-[(5-chloro-2- thienyl)methyl]-2,4-dimethyl-pentanamide (0.055 g, 50% yield) as a yellow gum : LC-MS (Method G), Rt = 1 .01 min; MS: (M+1 ) = 260-262;

¹ H NMR (400 MHz, CDCI3-d) δ ppm 0.92 (t, 6H) 1.18 (s, 3H) 1.34 (m, 1 H) 1 .73 (m, 2H) 2.63 (d, 1 H) 3.21 (d, 1 H) 5.61 (b, 1 H) 5.91 (b, 1 H) 6.56 (d, 1 H) 6.70 (d, 1 H).

Step 4: Preparation of 1 -(5-chloro-2-thienyl)-2,4-dimethyl-pentan-2-amine.

To a solution of 2-[(5-chloro-2-thienyl)methyl]-2,4-dimethyl-pentanamide (0.055 g, 0.21 mmol) in acetonitrile (0.33 M, 0.65 mL) and water (0.33 M, 0.65 mL) was added (Bis(trifluoroacetoxy)iodo)benzene (0.100 g, 1 .1 equiv., 0.23 mmol) and the solution was stirred at 60 °C for 4 h. The reaction mixture was diluted with dichloromethane and water, acidified with an aqueous solution of hydrochloric acid (1 M) and washed with

dichloromethane. The aqueous phase was then basified with an aqueous solution of NaOH (4 M) and extracted twice with dichloromethane. The organic phase was washed with brine, dried over Na2S0 ₄ , filtered and concentrated to give 1 -(5-chloro-2-thienyl)-2,4-dimethyl- pentan-2-amine (0.040 g, 82% yield) as a colourless gum : LC-MS (Method G), Rt = 0.70 min; MS: (M+1 ) = 232-234;

¹ H NMR (400 MHz, CDCI3-d) δ ppm 0.94 (dd, 6H) 1 .08 (s, 3H) 1 .30 (m, 2H) 1.77 (m, 1 H) 2.73 (s, 2H) 6.53 (d, 1 H) 6.73 (d, 1 H).

Step 5: Preparation of N-[1 -[(5-chloro-2-thienyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro- quinoline-3-carboxamide.

To a solution of 1 -(5-chloro-2-thienyl)-2,4-dimethyl-pentan-2-amine (0.040 g, 0.17 mmol) in dichloromethane (1 .7 mL, 0.1 M) and triethylamine (0.07mL, 3 equiv., 0.52 mmol) was added N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (0.037 g, 1 .1 equiv., 0.19 mmol) followed by 0-(7-azabenzotriazole-1 -yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate (0.074 g, 1 .1 equiv., 0.19 mmol) and 8-fluoroquinoline-3-carboxylic acid (0.036 g, 1.1 equiv., 0.19 mmol). The solution was stirred at rt for 16h. The reaction mixture was quenched with saturated aqueous NaHCC>3. The two phases were separated and aqueous phase was extracted twice with dichloromethane. The combined organic phase was washed with brine, dried over Na2S0 ₄ anhydrous, filtered and concentrated. Purification by flash chromatography gave N-[1 -[(5-chloro-2-thienyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro- quinoline-3-carboxamide (0.054 g, 77% yield) as a white solid, mp=126-128°C, LC-MS (Method G), Rt = 1 .21 min; MS: (M+1 ) = 405-407;

1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.02 (d, 6H) 1.46 (s, 3H) 1.59 (dd, 1 H)

1 .88 (m, 1 H) 2.1 1 (dd, 1 H) 3.18 (d, 1 H) 3.60 (d, 1 H) 5.89 (b, 1 H, NH) 6.59 (d, 1 H) 6.71 (d, 1 H) 7.49 (m, 1 H) 7.58 (m, 1 H) 7.70 (d, 1 H) 8.49 (s, 1 H) 9.19 (s, 1 H). Example 2: N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide

Step 1 : Preparation of N-(1 ,3-dimethylbutylidene)-2-methyl-propane-2-sulfinamide

To a solution of Isobutylmethylketone (13.7 ml_, 108.73 mmol) in tetrahydrofuran (218 ml_), was added (±) t-butylsulfinamide (13.585 g, 1 equiv., 108.73 mmol) was added followed by titanium (IV) ethoxide (34.19 ml_, 1.50 equiv., 163.09 mmol) and the solution was stirred at 60°C overnight. The reaction mixture was then cooled down to room temperature, and was slowly poured onto a mixture of 200 mL ethyl acetate and 200 mL saturated aqueous sodium bicarbonate solution. The mixture was stirred at room temperature for 30 min and filtered over a pad of celite. The filtrate was concentrated under reduce pressure and the residue was then filtered over a pad of silica gel and the silica pad was washed with cyclohexane / ethyl acetate (70:30).

The filtrate was concentrated under reduce pressure to afford N-(1 ,3- dimethylbutylidene)-2-methyl-propane-2-sulfinamide (15.4 g, 70 %) as a yellow liquid. LC- MS (Method G) UV Detection: 220 nm, Rt = 0.94 min;

¹ H NMR (CHLOROFORM-d) δ: 2.31 -2.35 (s, 3H), 2.25-2.30 (m, 1 H), 2.07-2.19 (m, 1 H), 1 .40-1 .47 (m, 1 H), 1 .19-1 .32 (s, 9H), 0.92-1.00 (dd, 6H). Step 2: Preparation of 1 -tert-butylsulfinyl-2-isobutyl-2-methyl-aziridine

To a suspension of trimethylsulfoxonium iodide (8.93 g, 39.3 mmol) in

dimethylsulfoxide (59.0 mL, 0.67 M) was added a solution of potassium t-butoxide (1 M in THF, 39.3 mL, 1 equiv., 39.3 mmol), and the reaction mixture was stirred at room

temperature for 45 min. N-(1 ,3-dimethylbutylidene)-2-methyl-propane-2-sulfinamide (4.00 g, 19.7 mmol) was then added, and the reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with water and extracted with ethyl acetate twice. The combined organic phase was washed with brine twice, dried over anhydrous magnesium sulfate, filtered and concentrated under reduce pressure to afford 1 -tert-butylsulfinyl-2- isobutyl-2-methyl-aziridine (3.99 g, 93%) as an inseparable mixture of isomers (1 :3) as a yellow liquid. The product was pure enough and used in the following step without further purification.

Isomer 1 : LC-MS (Method G)

UV Detection: 220 nm, Rt = 1 .09 min; MS: (M+1 ) = 218

1H NMR (CHLOROFORM-d) δ: 2.61 -2.65 (s, 1 H), 2.44-2.47 (s, 1 H), 1 .82-1 .90 (m,

1 H), 1 .41 -1 .48 (m, 1 H), 1 .29-1 .35 (m, 1 H), 1 .26-1 .28 (s, 3H), 1 .19-1.25 (m, 9H), 0.88-0.97 (t, 6H); Isomer 2: LC-MS (Method G)

UV Detection: 220 nm, Rt = 1 .1 1 min; MS: (M+1 ) = 218;

¹ H NMR (CHLOROFORM-d) δ : 2.41 -2.43 (s, 1 H), 1 .82-1 .90 (m, 1 H), 1 .69-1 .72 (s, 1 H), 1 .41 -1 .48 (m, 1 H), 1 .39-1.41 (s, 3H), 1 .29-1 .35 (m, 1 H), 1 .19-1 .25 (s, 9H), 0.88-0.97 (t, 6H).

Step 3: Preparation of N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-2-methyl- propane-2-sulfinamide

To a solution of 3,3-difluoropiperidine hydrochloride (0.3624 g, 2.0 equiv., 2.300 mmol) in dry tetrahydrofuran (1 .150 mL, 1 M) at room temperature under argon, was added dropwise a solution of isopropylmagnesium chloride-lithium chloride complex (1.3 M in THF, 1 .8 mL, 2.0 equiv., 2.300 mmol). The solution was stirred at room temperature for 2 h before 1 -tert-butylsulfinyl-2-isobutyl-2-methyl-aziridine (0.25 g, 1 .150 mmol) was added. The reaction mixture was stirred at room temperature for 45 min and then at 90°C for 2 days. The reaction mixture was then cooled down to room temperature and slowly quenched with water. The reaction mixture was then extracted with ethyl acetate twice. The combined organic phase was washed with water, saturated ammonium chloride solution, then dried over magnesium sulfate, filtered and concentrated under reduce pressure to afford N-[1 - [(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-2-methyl-propane-2-sulfinamide (282 mg, 72%) as a brown liquid as a mixture of isomers. The isomer mixture was used in the following step without further purification. Isomer 1 : LC-MS (Method G) UV Detection: 220 nm, Rt = 1 .10 min; MS: (M+1 ) = 338; ¹ H NMR (CHLOROFORM-d) δ: 4.22-4.27 (s, 1 H), 2.91 - 3.03 (m, 1 H), 2.70-2.83 (m, 2H), 2.48-2.59 (m, 1 H), 2.29-2.46 (m, 1 H), 1 .54-1 .90 (m, 7H), 1 .45-1 .54 (m, 1 H), 1 .35-1.39 (s, 3H), 1 .18-1.24 (s, 9H), 0.88-0.96 (m, 6H); Isomer 2: LC-MS (Method G) UV Detection: 220 nm, Rt = 1 .12min ; MS: (M+1 ) = 338

¹ H NMR (CHLOROFORM-d) δ: 4.22-4.27 (s, 1 H), 2.91 -3.03 (m, 1 H), 2.70-2.83 (m, 2H), 2.48-2.59 (m, 1 H), 2.29-2.46 (m, 1 H), 1 .54-1 .90 (m, 7H), 1 .45-1 .54 (m, 1 H), 1 .28-1 .33 (s, 3H), 1 .18-1.24 (s, 9H), 0.88-0.96 (dd, 6H). Step 4: Preparation of 1 -(3,3-difluoro-1 -piperidyl)-2,4-dimethyl-pentan-2-amine

To a solution of N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-2-methyl- propane-2-sulfinamide (0.28 g, 0.83 mmol) in methanol (2.585 mL, 0.4 M) was added dropwise a solution of hydrogen chloride (4 M in dioxane) (0.312 mL, 1 .5 equiv., 1 .24 mmol). The solution was stirred at room temperature for 2h 30 min and then the volatiles were removed under reduce pressure. The residue was partitioned between diethyl ether and water. The two phases were separated and the aqueous phase was washed with diethyl ether. The aqueous phase was basified with an aqueous sodium hydroxide solution (8 N) and then extracted with ethyl acetate twice. The combined organic phase was dried over magnesium sulfate, filtered and concentrated under reduce pressure to afford 1 -(3,3-difluoro- 1 -piperidyl)-2,4-dimethyl-pentan-2 -amine (99 mg, 51 %) as a brown liquid;

¹ H NMR (CHLOROFORM-d) δ: 2.72-2.87 (t, 2H), 2.52-2.64 (broad s, 2H), 2.25-2.33 (s, 2H), 1 .91 -2.12 (m, 2H), 1 .78-1 .90 (m, 2H), 1 .66-1 .78 (m, 3H), 1 .25-1 .34 (dd, 2H), 1 .03- 1 .12 (s, 3H), 0.86-1 .00 (m, 6H)

Step 5: Preparation of N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro- quinoline-3-carboxamide

To a suspension of 8-fluoroquinoline-3-carboxylic acid (0.080 g, 0.42 mmol) in acetonitrile (2.1 ml_, 0.2 M) was added triethylamine (0.178 ml_, 3.0 equiv., 1 .27 mmol) ,Ν,Ν- dimethylaminopyridine (2 mg), and then a solution of propylphosphonic anhydride (T3P®, 50% w/w in ethyl acetate, 0.503 ml_, 2.0 equiv., 0.845 mmol). The solution was stirred at room temperature then 1 -(3, 3-difluoro-1 -piperidyl)-2,4-dimethyl-pentan-2-amine (0.099 g, 1 .0 equiv., 0.42 mmol) was added, and the solution was stirred at room temperature overnight. The reaction mixture was then diluted with ethylacetate and washed with water three times, dried over magnesium sulfate, filtered and concentrated under reduce pressure. The residue was purified by flash chromatography (cyclohexane /ethyl acetate = 9:1 to 3:2) to give N-[1 -[(3, 3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide (53 mg, 31 %) as a yellow oil. LC-MS (Method G) UV Detection: 220 nm, Rt = 1 .00 min; MS: (M+1 ) = 408;

¹ H NMR (CHLOROFORM-d) δ: 9.26-9.36 (m, 1 H), 8.53-8.60 (s, 1 H), 7.67-7.75 (dd, 1 H), 7.52-7.59 (m, 1 H), 7.44-7.52 (q, 1 H), 6.96-7.09 (broad s, 1 H), 2.77-2.96 (m, 3H), 2.61 - 2.72 (m, 2H), 2.50-2.60 (dd, 1 H), 1 .84-1 .99 (m, 3H), 1 .69-1.83 (m, 4H), 1 .37-1 .47 (s, 3H), 0.90-1.05 (t, 6H).

Example 3: Preparation of the single isomers of N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3- dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide. N-[(1 R)-[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3- carboxamide

and

N-[(1 S)-[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide The racemic N-[1 -[(3,3-difluoro-1 -piperidyl)methyl]-1 ,3-dimethyl-butyl]-8-fluoro- quinoline-3-carboxamide mixture was submitted to chiral resolution by preparative HPLC chromatography using the conditions outlined hereafter. Analytical HPLC method:

SFC:Waters Acquity UPC ² /QDa

PDA Detector Waters Acquity UPC ²

Column: Daicel SFC CHIRALPAK ^® IA, 3μΓη, 0.3cm x 10cm, 40°C

Mobile phase: A: C0 ₂ B: EtOH gradient: 30% B in 1.8 min

ABPR: 1800 psi

Flow rate: 2.0 ml/min

Detection: 235 nm

Sample concentration: 1 mg/mL in ACN/iPr 50/50

Injection: 1 μΐ

Preparative HPLC method:

Autopurification System from Waters: 2767 sample Manager, 2489 UV/Visible Detector, 2545 Quaternary Gradient Module.

Column: Daicel CHIRALPAK® IA, δμηι, 1 .0 cm x 25cm

Mobile phase: Hept/EtOH 90/10

Flow rate: 10 ml/min

Detection: UV 265 nm

Sample concentration: 37mg/i

Injection: 130μΙ - 260μΙ,

Results:

Table E: Physical data of compounds of formula (I)

Entry STRUCTURE RT [M+H] Method MP

(min) (measured) °C

E18 1.16 419 G

E19 1.18 417 G 134 138

E20 1.15 397 G 140 144

E21 1.13 384 G

E22 1.07 200 G

E23 1.20 386 G

f 86

Entry STRUCTURE RT [M+H] Method MP

(min) (measured) °C

E30

E31

E32

E33

E34

E35

E36

Table F: Physical data of compounds of formula (I) as individual enantiomers No lUPAC name STRUCTURE RT [M+H] [α]ο ²⁰ method

(min meas

) ured

Detection: 235 nm

Sample

concentration: 1 mg/mL in ACN/iPr 50/50

Injection: 1 μΙ_

Biological examples

Botryotinia fuckeliana (Botrytis cinerea) I liquid culture (Gray mould)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (Vogels broth). After placing a (DMSO) solution of test compound into a microtiter plate (96- well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 3-4 days after application.

The following compounds gave at least 80% control of Botryotinia fuckeliana at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E1 , E2, E3, E4, E5, E6, E7, E8, E9, E1 1 , E12, E13, E14, E17, E18, E19, E20, E21 , E22, E23, E24, E25, E26, E27, E28, E29, E30, E31 , E32, E33, E34, E35, E36, E37, E38, F1 , F2 Glomerella lagenarium (Colletotrichum lagenarium) I liquid culture (Anthracnose)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is measured photometrically 3- 4 days after application.

The following compounds gave at least 80% control of Glomerella lagenarium at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E1 , E2, E3, E4, E5, E6, E8, E1 1 , E12, E13, E14, E15, E18, E19, E20, E21 , E22, E23, E24, E25, E26, E27, E28, E29, E32, E33, E34, E35, E36, E37, E38, F1 , F2

Fusarium culmorum I liquid culture (Head blight) Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 3-4 days after application.

The following compounds gave at least 80% control of Fusarium culmorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E1 , E2, E3, E4, E5, E6, E7, E8, E9, E1 1 , E12, E13, E14, E15, E17, E18, E19, E20, E21 , E22, E23, E25, E26, E27, E28, E29, E30, E32, E33, E34, E35, E36, E37, E38, F1 , F2

Fusarium culmorum I wheat / spikelet preventative (Head blight)

Wheat spikelets cv. Monsun are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. The spikelets are inoculated with a spore suspension of the fungus 1 day after application. The inoculated spikelets are incubated at 20 °C and 60% rh under a light regime of 72 h semi darkness followed by 12 h light / 12 h darkness in a climate chamber and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check spikelets (6 - 8 days after application).

The following compounds gave at least 80% control of Fusarium culmorum at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E3, E6, E9, E12, E14, E15, E24, E26, E30, E33, E34, E35, F2 Gaeumannomyces graminis I liquid culture (Take-all of cereals)

Mycelial fragments of the fungus from cryogenic storage were directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores iss added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application.

The following compounds gave at least 80% control of Gaeumannomyces graminis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E2, E5, E9, E12, E13, E14, E15, E18, E19, E30, E33, E34, E35

Gibberella zeae (Fusarium graminearum) I wheat / spikelet preventative (Head blight) Wheat spikelets cv. Monsun are placed on agar in multiwell plates (24-well format) and sprayed with the formulated test compound diluted in water. One day after application, the spikelets are inoculated with a spore suspension of the fungus. The inoculated test leaf disks are incubated at 20 °C and 60% rh under a light regime of 72 h semi darkness followed by 12 h light / 12 h darkness in a climate chamber, the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears on untreated check spikelets (6 - 8 days after application).

The following compounds gave at least 80% control of Gibberella zeae at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E3, E5, E30, E33, E34, E35

Monographella nivalis (Microdochium nivale) / liquid culture (foot rot cereals)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth (PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically 4-5 days after application.

The following compounds gave at least 80% control of Monographella nivalis at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E1 , E6, E14, E17, E19, E20, E21 , E23, E24, E33, E37, E38, F2

Magnaporthe grisea (Pyricularia oryzae) I liquid culture (Rice Blast)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth

(PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically

3-4 days after application.

The following compounds gave at least 80% control of Magnaporthe grisea at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E2, E3, E4, E5, E6, E7, E8, E9, E12, E13, E14, E15, E16, E21 , E26, E27, E30, E32, E33, E34, E37, E38, F1 , F2

Magnaporthe grisea (Pyricularia oryzae) I rice / leaf disc preventative (Rice Blast) Rice leaf segments cv. Ballila are placed on agar in a multiwell plate (24-well format) and sprayed with the formulated test compound diluted in water. The leaf segments are inoculated with a spore suspension of the fungus 2 days after application. The inoculated leaf segments are incubated at 22 °C and 80% rh under a light regime of 24 h darkness followed by 12 h light / 12 h darkness in a climate cabinet and the activity of a compound is assessed as percent disease control compared to untreated when an appropriate level of disease damage appears in untreated check leaf segments (5 - 7 days after application).

The following compounds gave at least 80% control of Magnaporthe grisea at 200 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E27, E30, E37, E38

Sclerotinia sclerotiorum I liquid culture (cottony rot)

Mycelia fragments of a newly grown liquid culture of the fungus are directly mixed into nutrient broth (Vogels broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format) the nutrient broth containing the fungal material is added.

The test plates are incubated at 24 °C and the inhibition of growth is determined

photometrically 3-4 days after application.

The following compounds gave at least 80% control of Sclerotinia sclerotiorum at 20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

F1

Mycosphaerella graminicola (Septoria tritici) I liquid culture (Septoria blotch)

Conidia of the fungus from cryogenic storage are directly mixed into nutrient broth

(PDB potato dextrose broth). After placing a (DMSO) solution of test compound into a microtiter plate (96-well format), the nutrient broth containing the fungal spores is added. The test plates are incubated at 24 °C and the inhibition of growth is determined photometrically

4-5 days after application.

The following compounds gave at least 80% control of Mycosphaerella graminicola at

20 ppm when compared to untreated control under the same conditions, which showed extensive disease development:

E1 , E21